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Obstructive sleep apnea (OSA) is a common chronic sleep disorder with a demanding and 
complex treatment regimen. Even though continuous positive airway pressure (CPAP) is a highly 
effective treatment for OSA, approximately 25% of those prescribed CPAP do not adhere. In 
accordance with a recent call for a biopsychosocial approach to address CPAP nonadherence, 
two studies were designed to investigate patient-centered factors of nonadherence. Study One 
was a laboratory-based experimental study with the aim to identify predictive variables of 
behavioral intentions to adhere to advantage- and disadvantage-framed health messages, which 
simulated receiving an OSA diagnosis and subsequent CPAP treatment recommendations. 
Multiple regression models indicated that higher behavioral intentions after viewing the 
advantage-framed message were expected from undergraduate participants endorsing higher 
positive emotional responses from the message and lower use of humor as a coping strategy. 
Higher behavioral intentions after viewing the disadvantage-framed health message were 
expected from undergraduate participants endorsing higher feelings of control, greater relative 
right hemisphere baseline cortical activity, higher levels of behavioral inhibition, and lower use 
of humor as a coping strategy. Study Two was a community-based study that aimed to identify
predictive variables of CPAP adherence in a clinical sample of adult patients with OSA. Logistic 
regression analyses were employed in accordance with current adherence criteria at seven, thirty, 
sixty, and ninety day time-points. Age significantly predicted nonadherence at sixty days, while 
age and subjective severity rating predicted nonadherence at ninety days. Multiple regression 
analyses were used to predict total hours of CPAP use at the same time-points, and were able to 
identify additional predictors with clinical utility. Age, race, and reward responsiveness trait 
were significant predictors of total hours of CPAP use at sixty days, while age and race were 
significant predictors at ninety days. Important clinical implications are discussed in light of 
findings for enhancing likelihood of CPAP adherence.
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CHAPTER I: INTRODUCTION 
 
While advances in healthcare are responsible for increases in life expectancy and overall 
quality of life, subpar adherence rates to such treatments have perplexed researchers for decades. 
On average, 25% of patients who are recommended complex treatment interventions do not 
adhere, which translates into significant health complications and approximately $300 billion 
(US) per year (DiMatteo, 2004). Patients who suffer from obstructive sleep apnea (OSA) are at 
even higher risk of nonadherence, with nonadherence rates to continuous positive airway 
pressure (CPAP) treatment ranging from 29% to 83% (Collard, Pieters, Aubert, Delguste, & 
Rodenstein, 1997; Grote, Hedner, Grunstein, & Kraiczi, 2000; Popescu, Latham, Allgar, & 
Elliott, 2001; Rauscher, Popp, Wanke, & Zwick, 1991; Weaver & Grunstein, 2008; Weaver et 
al., 1997; Wolkove, Baltzan, Kamel, Dahrusin, & Palayew, 2008). CPAP nonadherence research 
is shifting from investigation of biomedical variables that have alone shown little predictive 
power, to exploring psychosocial variables that are more promising at varying degrees across 
identified constructs (Engleman & Wild, 2003;  Weaver & Chasens, 2007; Weaver & Grunstein, 
2008). 
 
This movement towards inclusion of psychosocial variables in the study of CPAP 
adherence is reflective of the healthcare system’s general acknowledgement of the need for a 
holistic approach to patient care, especially for implementing complex and demanding 
interventions such as CPAP. In fact, it was not until very recently (Crawford, Espie, Bartlett, & 
Grunstein, 2014) that a formal call for a biopsychosocial approach to addressing CPAP 
adherence was made to the sleep medicine community and the healthcare system at large. Such 
an approach to patient care of those who suffer from OSA would reflect the movement from 
providers thinking in terms of “compliance” (e.g., the extent to which a person’s behavior aligns 
with health advice) to “adherence” (e.g., the extent to which a person’s behavior corresponds
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with agreed upon recommendations from a provider) (Sabate, 2001). Thinking in terms of 
“compliance” creates an environment where the patient is more likely to take a passive consumer 
role when gathering important health information. This also equates to a “doctor-centered” 
model, where the active mechanisms of change are assumed to be a physician’s instructions only, 
with little regard for a patient’s unique perspective or more complex person-centered factors 
(Crawford et al., 2014). 
In consideration of a biopsychosocial model of CPAP use, Crawford and colleagues 
(2014) were careful to consider the multidimensional nature of “nonadherence,” as defined by 
the World Health Organization (WHO) in 2001. The WHO determined that nonadherence is a 
result of four main factors, namely the healthcare system, condition-related factors, therapy- 
related factors, and patient-related factors (Sabate, 2001), which grossly map onto the three 
major domains comprising the biopsychosocial framework (condition- and therapy-related 
factors mostly subsumed under biomedical, patient-related factors subsumed under 
psychological, and healthcare system subsumed under sociocultural categories); however, all 
factors are thought to be fluidly related across domains at some level. Many researchers have 
begun delineating such variables through psychosocial health behavior models (e.g., Health 
Belief Model, Theory of Planned Behavior, and the Protection Motivation Theory). However, 
without careful consideration of the influences of biomedical factors on adherence through these 
frameworks, findings from these lines of research can pose similar threats to taking a completely 
holistic, patient-centered approach. A safeguard against such threats includes considering 
individual differences in predisposing traits and associated physiology in each domain of the 
biopsychosocial framework. Taking such an approach can provide clinicians and researchers
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alike a patient-centered lens through which to consider biomedical, psychological, and social 
factors influencing behavioral intentions and adherence behavior. 
In summary, a historically simple idea of “compliance” has proven to be a much more 
complex and important phenomenon that is best approached using a biopsychosocial framework. 
With countless variables influencing a patient’s ability to adhere to treatment recommendations, 
addressing treatment adherence concerns can be a daunting task for healthcare providers and 
researchers. Given the variability of the treatment adherence literature and the importance of 
treatment adherence for increased quality of life and survival, considering the mechanisms of 
perceiving health information at the neurophysiological and individual differences levels could 
help to inform existing theories used to explain nonadherence, and subsequently inform 
alterations in treatment and intervention protocols. Other implications include early identification 
of patients at risk of nonadherence, and provision of a feasible approach to delivering novel 
health information tailored to meet the needs of patients based on individual differences. 
 
The proposed study aimed to investigate individual differences related to the 
phenomenological experience of receiving health information. This has been explained using a 
biopsychosocial framework of CPAP adherence (Crawford et al., 2014) that incorporates 
relevant facets of Reinforcement Sensitivity Theory (RST) and considers the person/individual- 
centered factors of leading motivational health behavior change models. 
 
 
 
Specific aims included the following: 
 
1. Investigate predictive factors of CPAP adherence. 
 
2. Explore risk factors for nonadherence at important moments in the general sequence of 
receiving a diagnosis and treatment recommendations.
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3. Investigate potential message tailoring approach for enhancing behavioral intentions and 
adherence behavior.
 CHAPTER II: ADHERENCE LITERATURE REVIEW 
 
In 2002, the World Health Organization reported that chronic diseases were responsible 
for 88% of all deaths in the United States. Chronic diseases require long-term ongoing treatment 
adherence for patients to experience increased quality of life or even survival. As previously 
mentioned, about 25% of patients who are recommended complex treatment interventions do not 
adhere, which results in significant health and financial costs (DiMatteo, 2004). As a result of 
ongoing complications resulting from nonadherence, researchers have focused their efforts on 
delineating predictive risk factors. Research on medication adherence alone has uncovered over 
200 variables influencing patients’ adherence behaviors (Fenerty, West, Davis, Kaplan, & 
Feldman, 2012). 
Researchers have begun organizing predictive factors into constructs, including patient 
factors (e.g., substance use, health literacy), environmental or contextual factors (e.g., social 
support, socioeconomic status), patient-clinician relationship factors (e.g., clear communication, 
time spent explaining disease and treatment), disease factors (chronicity, severity, response to 
treatment), health care delivery factors (e.g., wait for appointments, convenience of clinic and 
pharmacy), and treatment regimen factors (e.g., pill burden, complexity, side effects) (Ingersoll 
& Cohen, 2008). Type of disease was also found to be associated with varying rates of 
nonadherence to treatment, with the highest adherence rates in patients with human 
immunodeficiency virus (HIV), arthritis, gastrointestinal disorders, and cancer, and the lowest 
adherence rates in patients with pulmonary disease, diabetes, and sleep disorders (DiMatteo, 
2004). Disease course was also related to nonadherence behavior, as patients with acute 
conditions generally demonstrate higher rates of adherence to treatment than patients with 
chronic diseases (DiMatteo, 1994; van Dulmen et al., 2007).
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The Health Belief Model, Theory of Planned Behavior, and Protection Motivation 
 
Theory were natural developments after consistent observations that psychosocial variables were 
significantly influencing adherence. Their development was timely, as major threats to life and 
health were shifting from infectious diseases to those of lifestyle and behavior. Today, 
psychosocial models are increasingly utilized to describe and explain high risk behaviors such as 
nonadherence associated with current leading causes of morbidity and mortality, including heart 
disease, atherosclerosis, obesity, cancers, and HIV infection (Bogart & Delahanty, 2004). 
While investigation of all high risk behaviors is imperative, adherence to a prescribed 
treatment regimen is especially important as these patients have already received or are at high 
risk for acquiring a diagnosis of a chronic or acute condition. Therefore, this review will focus on 
the ways in which the major psychosocial models have been used to describe and explain 
nonadherence to a prescribed treatment regimen for a diagnosed condition, also known as 
“treatment” or “secondary” nonadherence (Fenerty et al., 2012). As the present study does not 
explicitly test specific constructs of these major models, the purposes of this review are 
constrained to highlighting the ways in which researchers have already begun delineating 
predictive constructs of adherence behavior, and to exploring important underlying mechanisms 
pertaining to the influence of individual differences on these predictive constructs. 
Health Belief Model 
 
The Health Belief Model (HBM) was originally proposed in the late 1960s as a means to 
explain the decision-making process individuals experience about whether to adopt health 
behaviors (Rosenstock, 1966). It was the first of its kind to emphasize the importance of 
subjective perceptions of incoming health information and related benefits, barriers, and cues to 
action to making a behavioral change (Baban & Craciun, 2007).
7  
According to the HBM, individuals undergo a decision-making process by which they 
consider several factors related to a specific health behavior, including their perceptions about 
susceptibility to an illness, severity of the illness consequences, benefits of engaging in the health 
behavior, and barriers and costs of engaging in the health behavior. These subjective cognitive 
conclusions culminate into subjective beliefs about personal health threat as well as the 
effectiveness of a health behavior if adopted. Cues to action can also trigger adoption of a health 
behavior if belief conditions are optimal for internal or external triggers to be attended. The three 
main constructs of the HBM are health threat, effectiveness of a health behavior, and cues to 
action. The adoption of the health behavior is a function of these constructs, and this relationship 
is thought to be mediated by behavioral intentions (Baban & Craciun, 2007). 
While the HBM has been used to predict a wide range of health behaviors including 
regular exercise, general dietary behaviors, condom use, and smoking (see Bogart & Delahanty, 
2004, for a review), relevant to this study is how the HBM has been used to predict adherence to 
 
a prescribed treatment regimen. Much of the research done in the area of treatment adherence has 
indirectly used the HBM to compare differences between those who do and do not adhere to 
treatment. 
Some of the major findings in the literature to date include testing specific facets of the 
HBM. For example, patients who adhere to medication regimens are more likely to perceive a 
broad multitude of benefits to receiving the treatment than those who do not adhere, while those 
who do not adhere to medication regimens are more likely to perceive more costs of medication 
than those who adhere (Adams & Howe, 1993; Chan, 1984; Hogan, Awad, & Eastwood, 1983; 
Pool & Elder, 1986). Another major finding in the literature is that patients who do not adhere to
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medication regimens commonly report low perceived susceptibility to the illness as well as high 
costs to receiving the medication (Howanitz & Freedman, 1992; Pool & Elder, 1986). 
HIV and acquired immune deficiency syndrome (AIDS) are serious conditions that can 
be managed successfully with levels of at least 95% adherence to highly active antiretroviral 
therapy (HAART) (Barclay et al., 2007; Begley, McLaws, Ross, & Gold, 2008). These 
incredibly high adherence rates could mean the difference between sustained viral suppression 
and progression to AIDS for a patient with HIV, or life and death for a patient with AIDS. 
Therefore, it is imperative that researchers systematically investigate barriers to successful 
HAART adherence from the perspectives of patients suffering with one of these conditions. 
Malcolm, Ng, Rosen, & Stone (2003) qualitatively examined the beliefs about HIV/AIDS 
 
of patients with excellent adherence to HAART and compared them to the beliefs of patients 
with suboptimal levels of HAART. Among major findings, patients with excellent adherence to 
HAART believed that their adherence rates needed to be 90-100% to be effective, which speaks 
to the HBM construct of perceived effectiveness of a health behavior. On the other hand, patients 
with suboptimal adherence levels did not believe that the adherence rates needed to be that high, 
and were less likely to trust their healthcare providers. 
Similar findings emerged from a prospective, cross-sectional study of the HBM and 
additional factors such as neurocognitive status, self-efficacy, and age in patients with HIV 
(Barclay et al., 2007). Relevant to the HBM was the finding that lack of perceived treatment 
utility (i.e., perceived effectiveness of a health behavior) was a main predictor of poor adherence 
rates in younger patients over a one-month period using electronic monitoring technology. 
Another important finding regarding younger patients was that low self-efficacy was also a
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predictor of poor adherence rates. Interestingly, the sole predictor of poor adherence in older 
patients was decreased levels of neurocognitive functioning. 
Begley, McLaws, Ross, & Gold (2008) conducted a study assessing a reformulated health 
belief model that included the main constructs of the original HBM along with self-efficacy and 
several other psychosocial variables. Three significant predictors of protease inhibitor 
nonadherence emerged from analyses. Nonadherence was found to be associated with low 
adherence self-efficacy and seriousness of nonadherence consequences related to HIV, lack of 
perceived threat of consequences related to HIV illness, and multiple recreational drugs usage. 
Baloush-Kleinman and colleagues (2011) sought to examine the utility of the HBM in 
predicting adherence to antipsychotic medication in patients with schizophrenia using a 
naturalistic, longitudinal design focusing on the early stages of illness when nonadherence is 
most likely. Results from structural equation modeling indicated that the main predictors of 
adherence were symptom severity, being in the earlier stage of illness, and attitudes towards 
antipsychotic medication. More specifically, there were several predictors of positive attitudes 
towards antipsychotic medication, including negative symptoms of schizophrenia, possessing an 
awareness of medication needs and the social consequences of illness, and with patient 
perception of trust in the physician. Additionally, Budd, Hughes, and Smith’s (1996) found the 
constructs perceived susceptibility, perceived severity, and perceived benefits of adherence to 
antipsychotic medications to be main predictors of adherence in a group of highly adherent 
patients compared to those patients demonstrating low adherence. Given the high rates of 
nonadherence to antipsychotic medication in this population (approximately 74% within 18 
months of the CATIE clinical trial; Lieberman et al., 2005) and the negative consequences
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thereof, these findings offer great insight for health care providers into the importance of 
considering perceptions of patients when delivering antipsychotic medication regimens. 
Diabetes mellitus is another condition in which adherence rates to treatment regimens are 
crucial to overall health and life expectancy. Diabetes mellitus is a metabolic disease precipitated 
by defects in insulin secretion and/or insulin action, resulting in hyperglycemia. This can cause 
problems in the eyes, nerves, kidneys, heart, and blood vessels, and can reduce life expectancy 
by 20 years (Gillibrand & Stevenson, 2006). The diabetic treatment regimen consists of careful 
monitoring of diet and glycemic blood levels, as well as the adoption of many new health 
behaviors including but not limited to daily insulin injections, urine testing, dietary 
modifications, and exercise routines (Janz & Becker, 1984). Given the complexity of the diabetic 
regimen entailing the adoption of a high number of new health behaviors along with the chronic 
nature of diabetes mellitus, it is not surprising that adherence rates are rather low. 
The HBM has been used to investigate nonadherence to diabetic regimen in both children 
and adults. Brownlee-Duffeck and colleagues (1987) found that the perceived costs of adhering 
to the diabetic regimen, such as difficulty of injections or embarrassment of adhering to regimen 
in the company of friends, was the only significant predictor on self-reported adherence among 
patients aged 13 to 26 years old. They also found that perceived susceptibility and severity were 
significant predictors of glycated hemoglobin levels, which is an average measure of plasma 
glucose concentration over time. 
Bond, Aiken, & Somerville (1992) conducted a similar study on 56 adolescent 
outpatients with insulin-dependent diabetes mellitus to test the predictive utility of the HBM. 
Low perceived threat and high perceived benefits compared to costs were associated with the 
highest adherence rates. High threat and cues to seek treatment were associated with poor
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metabolic control, but poor metabolic control was not associated with nonadherence. Age was 
inversely related to adherence to the exercise, insulin injection, and frequency of engagement in 
the diabetic regimen. In this study, willingness and ability to act on cues was most closely 
associated with adherence. 
Seeking to improve the predictive utility of the HBM, Aalto, Uutela, and Aro (1997) 
conducted a study on 423 adults with Type I diabetes mellitus assessing the original constructs of 
the HBM and several additional variables and their associations with adherence to the diet and 
blood glucose self-monitoring components of the diabetic regimen. These additional variables 
included locus of control, self-efficacy, health value, and social support. Consistent with HBM, 
physiological cues to action were predictive of adherence to blood glucose self-monitoring. 
Diabetes-related social support was predictive of diet adherence. Consistent with the extended 
HBM, perceptions of benefits of adherence to the diabetic regimen were influenced by internal 
locus of control and self-efficacy for carrying out tasks required of the regimen (Aalto & Uutela, 
1997). 
 
Gillibrand and Stevenson (2006) sought to apply the extended HBM to young people 
(ages 16-25 years old) with Type I diabetes mellitus. High levels of family support predicted 
adherence to the self-care component of the diabetes regimen. However, high levels of family 
support in conjunction with low locus of control to manage their diabetes seemed to influence 
perception of severity and vulnerability to illness in an adverse way. High internal locus of 
control and high self-efficacy was associated with perceiving more benefits than costs of 
adhering to the self-care component of the diabetic regimen (Gillibrand & Stevenson, 2006). 
In summary, the HBM has been successfully utilized and extended to include other 
constructs to predict and study underlying mechanisms involving adherence to complex
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treatment regimens, such as diabetes and HIV treatments. In particular, self-efficacy and 
perceived threat influenced adherence to both treatment regimens. Perceived effectiveness of a 
health behavior influenced adherence to HIV regimen, while perceived costs and benefits of 
adherence, perceived susceptibility and severity of illness, and willingness to act on cues to 
action influenced adherence to diabetes regimen. Interestingly, a high internal locus of control 
and high self-efficacy was associated with perceiving relatively more benefits than costs of 
adherence to diabetes regimen. The HBM has also been used to study barriers associated with 
antipsychotic medication adherence. Perceived susceptibility, perceived severity, and perceived 
benefits of adherence were constructs that were found to influence adherence behaviors. One of 
the main considerations of each of the studies highlighted has been on person-centered variables, 
including a patient’s unique perceptions about the disease and about their abilities to follow 
through with treatment recommendations. 
Theory of Planned Behavior 
 
The Theory of Planned Behavior (TPB) was created as an expansion of the earlier Theory 
of Reasoned Action in an effort to broaden its applicability (Baban & Craciun, 2007). Thus, 
these theories overlap substantially in constructs, with the exception of the addition of perceived 
behavioral control to the TPB (Ajzen & Fishbein, 1980). Like the HBM, the TPB also stresses 
the role of perceptions in motivating actions toward adopting health behaviors. According to the 
TPB, intentionality is the most proximal cause of behavior. Furthermore, intentions are 
influenced by attitudes towards adopting a behavior, social norms, and perceived behavioral 
control. Attitudes are a cognitive summation of the perceived likelihood of acquiring an outcome 
by adopting a health behavior and the evaluation of that outcome. The more desirable the 
outcome is perceived by the individual, the more positive is the attitude towards adopting the
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health behavior. Social norms refer to the perception that other people whose opinion is highly 
valued want the individual to adopt the health behavior. Thus, an individual who is motivated to 
adhere to the desires of significant others will also be more likely to adopt the health behavior 
through the social norms construct of the TPB. Finally, perceived behavioral control is the 
individual’s subjective rating of difficulty level of adopting the health behavior, given the 
individual’s perceived resources and barriers to do so (Baban & Craciun, 2007). 
A meta-analytic review of 185 studies was conducted in an effort to test the utility of the 
TPB and its individual constructs (Armitage & Conner, 2001). Overall, the TPB was found to be 
a good predictor of both behavior and intention. Specifically, the TPB explained 27% of the 
variance in individuals’ actual behavior, and 39% of the variance in their intentions. All 
constructs except for subjective norms were found to be good predictors of intentions or 
behaviors. The weakness of the subjective norms construct points to poor measurement of this 
construct in past research and the need to provide a better definition or its expansion within the 
TPB (Armitage & Conner, 2001). 
Generally, the TPB has been successful at predicting a wide-range of health behaviors, 
including healthy dietary changes (Astrom & Rise, 2001; Conner, Norman, & Bell, 2002; Payne, 
Jones, & Harris, 2004; Povey, Conner, Sparks, James, & Shepherd, 2000), exercise (Godin & 
Kok, 1996), adolescent smoking (Higgins & Conner, 2003), and student alcohol and tobacco use 
(McMillan & Conner, 2003). The TPB has also been used to predict health screening behaviors 
(Bowie, Curbow, LaVeist, Fitgerald, & Zabora, 2012; Conner & Sparks, 1996; O’Neill et al., 
2008) and AIDS preventive behavior (Terry, Gallois, & McCamish, 1993). 
 
Dietary and physical activity are common elements of treatment regimens for patients 
suffering from chronic illnesses or recovering from procedures used to treat chronic diseases,
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such as cardiac disease, diabetes, obesity, and weight loss surgery. In addition to the general 
findings indicating that the TPB is a useful predictor of dietary behavior, the TPB has been used 
to investigate low-fat food consumption (Armitage & Conner, 1999; Paisley & Sparks, 1998), 
eating foods that are high in saturated fats (de Brujin, Kroeze, Oenema, & Brug, 2008), and 
healthy eating among participants at risk for diabetes (Blue, 2007). Recently, the TPB has been 
used to explain adherence to healthy eating regimens prescribed for different health conditions, 
including Type 2 diabetes and cardiovascular disease (White, Terry, Troup, Rempel, & Norman, 
2010). In a one-month study, a group of researchers utilized the TPB to determine predictive 
factors of such a dietary regimen for patients with Type 2 diabetes, cardiovascular disease, or 
with both conditions. Results indicated that attitude and subjective norms were predictive of 
intentions to adhere to the dietary regimen. Furthermore, intentions and perceived behavioral 
control were associated with behavioral adherence via self-report. Interestingly, an additional 
variable, planning, was assessed and found to directly predict treatment adherence (White et al., 
2010). 
 
The TPB has also successfully predicted exercise behavior in a general sample of 
participants (Godin & Kok, 1996), as well as in a cardiac rehabilitation sample (Godin, Valois, 
Jobin, & Ross, 1991), and among college undergraduates and cancer survivors (Rhodes & 
Courneya, 2003). Other research has indicated that perceived behavioral control was a significant 
predictor of undergraduate women’s intentions to exercise (Gatch & Kendziershi, 1990), and was 
the only variable that directly influenced exercise behavior in college students (Bryan & 
Rocheleau, 2002). 
Blanchard, Courneya, Rodgers, Daub, and Knapic (2002) conducted a study utilizing the 
 
TPB to better understand motivation to exercise in participants undergoing Phase 2 of cardiac
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rehabilitation, which suffers poor adherence rates despite potential significant quality of life 
increases. Eighty-one patients enrolled in a Phase 2 cardiac rehabilitation program completed 
questionnaires assessing each TPB construct before and after the program. They found that 
attitude, subjective norm, and perceived behavioral control successfully predicted exercise 
intentions (38% of the variance), which in turn predicted exercise adherence (23% of the 
variance) during Phase 2 cardiac rehabilitation program. TPB constructs explained more of the 
variance in exercise intentions at follow-up (51%), but exercise intentions still only explained 
23% of the variance in exercise adherence (Blanchard et al., 2002). 
 
In summary, the TPB is similar in many aspects to the HBM as it maintains that a 
patient’s perceptions influence a decision of adherence. The TPB maintains that the most 
proximal cause of adherence behavior is one’s behavioral intentions to adhere. These intentions 
are influenced by attitudes towards adopting adherence behavior, social norms about adherence 
to a treatment regimen, and perceived behavioral control. In the studies reviewed above, the TPB 
demonstrated good predictive utility for both behavioral intentions and adherence behavior. Main 
constructs that were especially useful throughout the reviewed studies included attitude, 
subjective norms, perceived behavioral control, which predicted behavioral intentions and in turn 
predicted adherence behavior. 
Protection Motivation Theory 
 
Protection Motivation Theory (PMT) is another psychosocial model that places people’s 
subjective appraisals of incoming information at the forefront of explaining resulting behaviors 
(Rogers, 1975). A unique addition to the decision-making process that has been described across 
models thus far is the idea that emotion, specifically fear, elicits cognitive responses that result in 
target health behavior adoption (Baban & Craciun, 2007). Another unique component of the
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PMT is the inclusion of personality variables and prior experiences as intrapersonal sources of 
information that are assumed to affect the cognitive mediating processes in the overall model 
(Floyd, Prentice-Dunn, & Rogers, 2000). Protection motivation is the impetus for a set of 
adaptive responses that result from both threat appraisal and coping appraisal. Similar to the 
HBM, increased perceived vulnerability to illness and perceived severity of the illness are 
thought to positively influence the probability of adopting the health behavior, but the motivation 
in the PMT is to protect oneself from the negative consequences of not adopting the health 
behavior. Fear arousal is thought to enhance protection motivation by increasing the perceived 
severity and vulnerability constructs. These constructs make up the threat appraisal process, 
while the coping appraisal process is an evaluation of response efficacy (i.e., adopting health 
behavior will result in threat removal) and self-efficacy (Baban & Craciun, 2007; Floyd, 
Prentice-Dunn, & Rogers, 2000). 
Floyd, Prentice-Dunn, and Rogers (2000) conducted a meta-analysis of the PMT, and 
found that the effect sizes for all model variables were statistically significant and in the 
hypothesized directions, indicating a sound model for predicting health behavior adoption. 
Within this meta-analysis were studies on specific health problems and the adoption of protective 
health behaviors, such as AIDS prevention, cancer prevention, smoking cessation, medication 
adherence, and healthy diet and exercise. Overall, coping beliefs were important in participants’ 
decisions to adopt a protective health behavior in all of the previously mentioned health 
problems, but were especially important in medication adherence and AIDS prevention (Floyd, 
Prentice-Dunn, & Rogers, 2000). Additionally, the PMT has been used as a good predictor of 
adopting protective health behaviors in fetal alcohol spectrum disorders prevention (Cismaru, 
Deshpande, Thurmeier, Lavack, & Agrey, 2010) sport injury rehabilitation adherence (Brewer et
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al., 2003), adherence to asthma treatment regimens (Bennett, Rowe, & Katz, 2012; Schaffer & 
Tian, 2004), and adherence to diabetes treatment regimens (Palardy, Greening, Ott, Holderby, & 
Atchison, 1998). 
As previously mentioned, physical activity is often incorporated into a treatment regimen 
for chronic diseases such as cardiovascular disease and diabetes. Plotnikoff and Higginbotham 
(2002) investigated the PMT’s utility in predicting adherence to physical activity regimens in 
two community samples characteristic of high rates of coronary heart disease. Consistent with 
general findings, coping beliefs were strongly and positively correlated with exercise outcome 
measures than PMT’s threat appraisal constructs. 
Tulloch and colleagues (2009) also investigated PMT’s utility in predicting exercise 
regimen adherence in patients with coronary artery disease. They assessed patients’ coping and 
threat appraisals according to PMT at time of hospital discharge, and again at two and six 
months post discharge. They also assessed patients’ exercise behavior at time of hospital 
discharge, and again at six and twelve months post discharge. Self-efficacy, response self- 
efficacy, and perceived severity successfully predicted intentions of exercise regimen adherence, 
and these intentions predicted exercise behavior, except at twelve months post discharge. 
Plotnikoff, Lippke, Trinh, Courneya, Birkett, & Sigal (2010) also investigated the 
usefulness of the PMT for predicting exercise regimen adherence in patients with type 1 and type 
2 diabetes. Overall, the PMT was effective in predicting adherence intentions and behavior in 
both groups. Specifically, self-efficacy was a stronger predictor than response efficacy of 
exercise adherence intentions. Self-efficacy and intention were significantly related with 
adherence behavior (Plotnikoff et al., 2010).
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In summary, the PMT makes uniquely valuable contributions to the motivational health 
behavior change literature by incorporating affective processes and personality variables as 
potential mediating processes that lead patients to decide to adhere. It also incorporates a 
“protection motivation” construct, which serves as a catalyst for an individual to engage in 
coping responses that are congruent with their predisposing traits and affective tendencies. Like 
the HBM, perceived illness severity has predicted behavioral intentions to engage in an exercise 
regimen, and like the TPB, these intentions subsequently predicted adherence behaviors. 
Similarly, self-efficacy was also associated with adherence intentions and behaviors in the 
studies previously reviewed. In accordance with the PMT, coping beliefs were also predictive of 
adherence. 
Measuring Adherence 
 
While there is currently no gold standard of measuring treatment adherence behaviors, 
both objective and subjective methods have been employed in adherence research (Brown & 
Bussell, 2011; Fenerty et al., 2012). Objective methods include counting pills, referencing 
pharmacy refill records, using electronic medication event monitoring systems, or taking 
biochemical measurements of an added nontoxic marker to medication in blood or urine samples. 
Subjective methods include interviewing patients, caregivers, family members, and physicians 
about medication use or by employing one of several theoretically-driven self-report inventories 
about medication adherence attitudes (Brown & Bussell, 2011). An additional benefit to using a 
theoretically-driven self-report inventory in conjunction with other forms of adherence 
measurement methods is that these inventories can provide insight into patients’ subjective 
beliefs and intentions surrounding treatment adherence and thus can inform subsequent effective 
intervention practices.
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Several self-report inventories have been validated for use of measuring antipsychotic 
medication adherence attitudes, including the Drug Attitude Inventory (Sajatovic et al., 2010), 
Medication Adherence Rating Scale (Fialko et al., 2008; Thompson, Kulkami, & Sergejew, 
2000), and Brief Adherence Rating Scale (Byerly, Nakonezny, & Rush, 2008). Only a few 
inventories have been developed for the purpose of predicting adherence attitudes outside of the 
realm of antipsychotic medication adherence. The Adherence Attitude Inventory was developed 
to assess four factors empirically associated with treatment adherence, namely cognitive 
functioning, patient-provider communication, self-efficacy, and commitment to adherence 
(Lewis & Abell, 2002). It has demonstrated preliminary evidence for use measuring adherence 
attitudes to HAART in HIV/AIDS patients (Lewis & Abell, 2002), as well as measuring 
adherence attitudes to antidepressant medication in older adults (50 years of age or older) with 
major depressive disorder (Sun et al., 2011). 
Summary and Implications 
 
The HBM, TPB, and PMT are all motivational models of health behavior change, which 
work on the assumption that drive or motivation is enough for health behavior adoption 
(Armitage & Conner, 2000). They have been utilized to predict health behavior adoption and to 
elucidate underlying mechanisms to inform interventions aimed at increasing adherence rates to 
treatment regimens (Baban & Craciun, 2007). While each model posits different constructs and 
underlying mechanisms of health behavior, a major similarity among the HBM, TPB, and PMT 
is the importance placed on subjective perceptions of incoming health information, and the 
subsequent cognitive decision-making process that ultimately provides the impetus for successful 
health behavior adoption. In short, each model emphasizes the individual’s subjective cognitive 
process of forming behavioral intentions about a proposed health behavior, and its objective
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behavioral result. As each of these models have been validated for use in health behavior 
prediction, it is highly likely that these common factors are indeed worth measuring clinically as 
a means to inform interventions. 
Even with this good amount of evidence, few self-report inventories have been created to 
assess treatment adherence attitudes outside the realm of antipsychotic medication adherence 
studies. An additional challenge in treatment adherence research is the lack of a gold standard for 
measuring patient adherence behaviors, as subjective assessments are considerably unreliable 
and objective assessments are typically expensive and unrealistic for use outside of research 
studies (Brown & Bussell, 2011). Nevertheless, after decades of adherence research, it is clear 
that patient’s subjective cognitions about a health condition and the adoption of a treatment 
regimen are important predictors of adherence despite these barriers to consistent measurement 
(Martin, Williams, Haskard, & DiMatteo, 2005). 
While continued research is warranted for further delineation of such variables 
contributing to the complexities of treatment adherence, researchers should also consider in more 
detail the impact of individual differences on patient perception of novel health information. 
Most effective interventions for treatment adherence target one or more of the aforementioned 
nonadherence factors; however, an investigation of individual differences in the perception of 
health information, particularly when a patient receives a new diagnosis with treatment 
recommendations, may uncover invaluable knowledge regarding mechanisms to adherence that 
fundamentally affect patient decision-making. As such, a review of the individual differences 
literature follows.
 CHAPTER III: INDIVIDUAL DIFFERENCES LITERATURE REVIEW 
 
In general, broad facets of life are universally similar. There are many physical, 
developmental, cognitive, affective, and behavioral similarities that come with the experience of 
being human. This idea is reflected in the commonalities found among major health behavior 
change models used to predict and explain underlying mechanisms of treatment adherence. As 
subjective perceptions of incoming health information are at the core of each of the 
aforementioned motivational models, an investigation of individual differences is warranted. 
This phenomenological approach to studying adherence behavior, cognitive appraisals, and 
emotional experiences puts particular emphasis on that which makes each person unique. 
Studying individual differences can provide insight into the complexities of adherence, thus 
allowing for better understanding and prediction of adherence intentions and resulting behaviors 
(Hamann & Canli, 2004). 
Personality and Health Behaviors 
 
Research investigating the relationship between personality and health typically addresses 
one of three issues. The first issue is the potential causal effect personality has on the 
development and course of disease through physiological effects of stress. The second issue 
addresses how personality is related to engaging in specific healthy or risky behaviors, which in 
turn affect the risk of developing a new illness or exacerbation of current illness. The third issue 
relates to the moderating influence personality may have on the impact of acute medical stressors 
and the demands of chronic medical illness on the body to make physiological, psychological, 
and social adjustments (Smith & Williams, 1992). 
 
Past research in this area has addressed the first of these issues, that is, the degree to 
which personality traits are causally related to physical illness. For example, an important line of
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research investigating the relationship between Type A behavior and coronary heart disease was 
a driving force in the re-instigation of personality and health investigations. Type A behavior 
consists of hostility, competitiveness, and achievement striving, with hostility being a major 
contributor to heart disease (Dembroski, MacDougall, Costa, & Grandits, 1989). An expert panel 
of the American Heart Association concluded that Type A personality was a significant risk 
factor for heart disease, as people with Type A pattern were two times as likely to develop heart 
disease as people with a Type B pattern of easygoing, patient, and soft-spoken personality traits 
(Cooper, Detre, & Weiss, 1981). 
Another example of research addressing the causal relationship between personality and 
physical illness is the more recent line of research on optimism. Optimism refers to a person’s 
stable expectation of good outcomes (Carver & Scheier, 1982). According to Carver and Scheier 
(1982), higher levels of optimism result in the tendency to actively cope with stressors, thus 
alleviating physiological stress responses by lessening the effects of emotional adjustment. This 
hypothesis was supported in optimistic cardiac surgery patients who showed better postoperative 
recoveries and less likelihood of intra-operative myocardial infarction compared to less 
optimistic patients (Scheier et al., 1989). 
While much research has addressed the first issue of personality’s causal relationship 
with health, research utilizing the Five-Factor Model has addressed the second issue related to 
the prediction of engaging in health behaviors (Costa & McRae, 1985; Goldberg, 1990). The 
Five-Factor Model evolved from decades of personality research beginning with the works of 
Allport and Odbert in 1936, who scoured the English language for terms describing personality 
traits. Catell later (1943) used Allport and Odbert’s list of 18,000 terms to ultimately create sets 
of bipolar trait scales that were eventually trimmed down to five factors (Goldberg, 1990).
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Through adequate factor analyses, these five factors have evolved into the following constructs: 
Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Openness (McCrae & Costa, 
1985). 
 
The Five-Factor Model has endured considerable criticism since its inception, including 
its major assumption that spoken language could systematically explain and reasonably reflect a 
concept as dynamic and complex as personality (McAdams, 1992). Nevertheless, the Five-Factor 
Model and its individual constructs continue to be used as a framework for investigating 
individual differences in adherence rates and health behaviors. For example, Extraversion, which 
is the tendency to be outgoing and experience positive emotions, was found to be associated with 
engaging in preventive health behaviors (Blumenthal, Sanders, Wallace, Williams, & Needles, 
1982). Neuroticism, the tendency to experience emotional distress, was found to be associated 
with risky health behaviors and lack of healthy behaviors (Brook, Whiteman, Gordon, & Cohen, 
1986, 1986; Mechanic & Cleary, 1980; Spielberger & Jacobs, 1982). Conscientiousness, the 
tendency to be methodical, reliable, and goal-oriented, and Agreeableness, the tendency to be 
tolerant and accepting, were found to be associated with healthy behaviors in a sample of Navy 
and Marine recruits (Booth-Kewley & Vickers, 1994). 
In an effort to more specifically address the second main issue of personality and health, 
studies connecting the relationship between personality traits and adherence to prescribed health 
regimens have been conducted. Christensen and Smith (1995) used the Five-Factor Model of 
personality traits and the HBM to examine medical regimen adherence in 72 renal dialysis 
patients. The only significant personality factor associated with medication adherence was 
Conscientiousness. Conscientiousness, however, was not significantly correlated with adherence 
to the dietary component of the prescribed regimen. In a similar study with 70 hemodialysis
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patients, Wiebe & Christensen (1997) found that an interaction between Conscientiousness and 
health beliefs (mostly perceived severity) significantly predicted individual differences in serum 
phosphorus levels, which is a measure of regimen adherence. Furthermore, they found that high 
Conscientiousness in combination with high perceived severity was associated with lower 
adherence rates. Researchers speculated that this pattern could be resulting from ineffective 
coping strategies such as avoidant coping associated with high levels of anxiety (Wiebe & 
Christensen, 1997). 
Individual Differences and Health Behaviors 
 
While past research on personality and health has utilized the HBM in conjunction with 
the Five-Factor model, other researchers have used the PMT with its uncertainty orientation 
construct as an individual difference variable in health behavior adherence. As previously 
explained, PMT posits that whether a person adopts a health behavior after receiving a health 
message (e.g., a diagnosis, instructions for treatment, etc.) depends on several conditions, 
including the severity of the health threat, perceived vulnerability to the threat, how efficacious 
the health behavior is perceived to be at alleviating the threat (response-efficacy), and perceived 
self-efficacy for carrying out the health behavior. When someone encounters a health message, 
two cognitive processes are activated that influence the cognitive factors previously described: 
threat appraisal and coping appraisal. Protection motivation is the integration of these two 
processes, which serves as a mediator to engaging in the health behavior as a means to protect 
the self from harm (Brouwers & Sorrentino, 1993). 
Another factor consistent with the PMT that has been hypothesized to contribute to the 
likelihood of an individual adopting a health behavior is uncertainty motivation. Uncertainty 
motivation is the extent to which individuals are motivated to deal with uncertainty about the
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self. Brouwers and Sorrentino (1993) hypothesized that uncertainty motivation, perceived 
efficacy (coping appraisal), and perceived threat (threat appraisal) would interact to predict 
health-related information seeking behaviors. One hundred fifty-five participants read one of 
several versions of an educational essay on a health condition and its corresponding treatment, 
which varied upon levels of threat and efficacy. In agreement with hypotheses, participants who 
were high on uncertainty orientation sought more health-related information as threat and 
efficacy increased, while those who were higher on certainty orientation sought more health- 
related information as either threat or efficacy increased. 
While the PMT is a sound framework for prediction and explanation of health behavior 
adoption, there are still aspects of receiving health information left to be determined, such as the 
valence of the health message and the corresponding psychophysiology effects of receiving such 
information. Another framework for studying such phenomena exists, namely Reinforcement 
Sensitivity Theory (RST), and includes comprehensive measures of individual differences that 
can be used in conjunction with motivational models of health behavior to further elucidate 
adherence to prescribed treatment regimens. 
Reinforcement Sensitivity Theory 
 
A common approach to studying individual differences is to use dimensions of RST. This 
theory has been described as a neuropsychology of affective, motivational, and cognitive factors 
(Smillie et al., 2006). The premise of RST is that motivation and emotion may consist of the 
central physiological processes underlying personality (Depue & Collins, 1999). However, RST 
was not created or originally conceptualized as a way to describe personality, but instead as a 
theory of neurobiological systems suggested to relate to personality (Carver & White, 1994).
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RST has evolved drastically since its formation in the 1970s by Jeffrey Gray from basic 
animal learning research (Smillie et al., 2006). RST was then used as a way to better understand 
anxiety and impulsivity. It was observed that rodents involved in basic animal learning research 
shared common biological systems related to anxiety and impulsive behaviors in the context of 
reinforcements. These behaviors varied among individual rodents in a stable and heritable way, 
comparable to dispositional attributes of humans, commonly referred to as personality traits. 
According to Gray (1990), cognition and emotion are two distinct variables that should be 
thought of as a function of adaptive, reinforcement behaviors, which shape personality. The 
notion that personality could be accounted for using physiological, motivational, and emotional 
concepts revolutionized the way that personality research was conducted thereafter (Leue & 
Beauducel, 2008; Smillie et al., 2006). 
Traditionally, RST consisted of three systems, namely the Behavioral Activation System 
(BAS), the Behavioral Inhibition System (BIS), and the Fight/Flight System (FFS). These 
systems were thought to have distinct neural pathways, and are now typically examined via self- 
report scales (Carver & White, 1994). The BAS was considered to be the reward system, while 
the BIS was considered the punishment system. The FFS was conceptualized as a threat-response 
system. 
The BAS has been associated with experiencing positive emotions, like happiness, 
commonly connected with approach behavior, resulting from mesolimbic dopaminergic reward 
system pathways (Demaree, Robinson, Everhart, & Youngstrom, 2005). The BIS on the other 
hand has been associated with experiencing negative affect, like fear, commonly associated with 
inhibition. The BIS has also been associated with anxiety, and is thought to be sensitive to 
signals of punishment, nonreward, and novelty (Carver & White, 1994). Neurophysiologically,
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the BIS is modulated by adrenergic and serotonergic pathways (Demaree et al., 2005). The BIS 
was traditionally the central focus of RST, while the FFS was considered to be a mediator of 
responses to unconditioned aversive stimuli. Activation of the FFS resulted in rapid escape or 
defensive aggression. Activation of these systems was thought to lead to affective dimensions of 
positive and negative mood. Individual differences in this activation and reactivity of the BIS 
and BAS were believed to correspond to stable differences in emotionality and resulting 
behavioral tendencies as they were reinforced over time (Smillie et al., 2006). 
The current conceptualization of RST is very similar to traditional RST. There are still 
three systems, namely the BIS, BAS, and a newly revised Fight/Flight/Freezing System (FFFS), 
and activation of each results in grossly similar kinds of behaviors outlined previously. The 
revised RST has some important modifications (Gray & McNaughton, 2000). The BAS is now 
more broadly conceptualized as being a mediator of responses to all appetitive stimuli, not just 
stimuli that have been conditioned as was previously posited. The FFFS is also a broader concept 
in that it is thought to be a mediator of responses to all aversive stimuli, not just unconditioned 
stimuli. The BIS is still the central focus of RST, and is still believed to be associated with 
anxiety. The main revision of the BIS is that it is activated by sources of conflict instead of being 
responsive to aversive stimuli. A source of conflict is defined as any experience that 
simultaneously activates the BAS and FFFS. Importantly, the BIS is no longer considered as a 
punishment system, but instead a conflict detection and resolution mechanism (Smillie et al., 
2006). 
 
Psychophysiology and RST. Since RST implies the importance of neurophysiology, 
much research has included the use of psychophysiological measures such as 
electroencephalography (EEG) and event-related potential (ERP). EEG is recorded from the
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scalp and measures electrical activity generated by the brain, especially the cortex (Coles & 
Rugg, 1995). Generally, EEG is a noninvasive measure of spontaneous voltages created by 
currents that flow when many pyramidal neurons experience synaptic excitation of their 
dendrites in synchrony (Bear, Connors, & Paradiso, 2007). Researchers investigating RST and 
individual differences in resting EEG have found differences across levels of BIS and BAS with 
relative baseline asymmetry. For example, BAS has been associated with greater relative left 
frontal asymmetry, while BIS is associated with greater relative right frontal asymmetry (Sutton 
& Davidson, 1997). Some research has also indicated that BAS is associated with at least one 
negative emotion, namely anger, with observed greater left frontal activity due to its approach 
motivation tendencies (Harmon-Jones & Harmon-Jones, 2010). Resting baseline asymmetry is 
typically recorded at different time points in an experiment for blocks of time in minutes. During 
this time, the participant is exposed to minimal sensory stimuli and is asked to relax and remain 
still so as to not include sensory, cognitive, or motor artifact in the EEG. 
While resting baseline asymmetry offers insight into individual differences associated 
with cortical arousal and correlated enduring traits, one way to gain insight into cognitive and 
emotional events that occur at the subsecond level is to examine event-related potentials, or 
ERPs. ERPs are voltage changes that occur as a result of the brain’s response to a presented 
stimulus, and are thought to represent summated post-synaptic changes in neurons (Coles & 
Rugg, 1995). ERPs are recorded from a participant via electrodes evenly distributed across the 
scalp while the participant engages in an experimental task. Positive and negative deflections of 
voltage (e.g., N1, P1, N2, P2, etc.) are of particular interest in cognitive neuroscience research, as 
are the latencies in milliseconds, ordinal sequence in deflection order, amplitudes in microvolts 
of these deflections, and placement of electrodes that provides the pattern of a component’s
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voltage gradient over the scalp, which is believed to indicate underlying neuroanatomical activity 
(Friedman, Cycowicz, & Gaeta, 2001). The P300 is a special ERP response to novel stimuli 
presentations, and is thought to reflect dopaminergic modulatory effects of the locus coeruleus- 
norepinephrine system in decision-making (Coles & Rugg, 1995; Nieuwenhuis, Aston-Jones, & 
Cohen, 2005). The P300 is a positive displacement that usually occurs between 250ms and 
500ms after stimulus presentation, and can be elicited using an oddball paradigm task, where 
participants are presented with frequently occurring stimuli and infrequently occurring deviant 
stimuli. In active oddball paradigm, participants are asked to respond to the infrequently 
occurring stimuli by either silently counting them as they are presented or by reaction time 
responses using a response device. The P300 occurs in response to the “oddball” or infrequently 
occurring stimuli presentations (Friedman, Cycowicz, & Gaeta, 2001). 
For example, De Pascalis, Strippoli, Ricardi, & Vergari (2004) conducted an emotional- 
word recognition task using a visual oddball paradigm to test individual differences in anxiety 
and impulsivity according to Gray’s RST at the electrophysiological level. Higher P300 peaks 
were observed over parietal and occipital electrode sites during target word presentations while 
in the emotionally incongruent conditions. P300 amplitudes varied across individual differences 
in anxiety at frontal and temporal electrode sites, as P300 amplitudes were larger in high-anxiety 
participants for unpleasant words compared to low-anxiety participants. Smaller P300 peaks 
were observed in high-impulsivity participants for negatively valenced targets over parietal and 
occipital electrode sites and longer P300 latencies over all electrode sites. These findings support 
the idea that individuals who are high in trait anxiety are more sensitive to negative information, 
but findings did not support the hypothesis that individuals who are high in impulsivity are more
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sensitive to positive information. Instead, results support the “joint subsystems” hypothesis that 
 
predicts high impulsivity to be associated with attenuated sensitivity to punishment (Corr, 2002). 
 
Similar emotional arousal effects have been demonstrated in both passive and active 
oddball paradigms (Delplanque, Silvert, Hot, & Sequeira, 2005; Keil et al., 2002; Mini, Palomba, 
Angrilli, & Bravi, 1996; Schupp et al., 2000), with the largest P300 responses over parietal 
electrodes (Olofsson, Nordin, Sequeira, & Polich, 2008; Sabatinelli, Lang, Keil, & Bradley, 
2007). Arousal levels were found to be the primary determinant of P300 orienting responses over 
valence in a visual oddball paradigm utilizing the International Affective Pictures System (IAPS; 
Lang, Bradley, & Cuthburt, 2001) (Rozenkrants & Polich, 2008). 
In an effort to elucidate underlying mechanisms of risky sexual practices, Lust and 
Bartholow (2009) used a visual oddball task in which pictures of condoms and alcoholic 
beverages from the IAPS were infrequently occurring stimuli among neutral, positive, and 
negative context images. They also assessed participants’ evaluations of condoms via self-report 
measures. Self-reported condom evaluations were overall positive among participants, but P300 
responses indicating novelty were smallest to pictures of condoms during the negative context 
condition, indicating that participants may be overriding their initial negative perceptions of 
condoms to report positive evaluations due to social norms that stress the benefits of condom use 
(Lust & Bartholow, 2009). 
RST and Health Behaviors. Recent attention has been given to the observation that men 
seek psychological help significantly less often than women (Deane & Todd, 1996). In order to 
investigate this disparity, Tsan, Day, Schwartz, and Kimbrel (2011) assessed the relationship 
between restrictive emotionality, BIS, BAS, and psychological help-seeking behavior in 285 
male college students. Results indicated that restrictive emotionality predicted both BIS and
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attitudes towards psychotherapy. Furthermore, BAS Drive also predicted attitudes towards 
psychotherapy. 
As health messages are typically received in an effort to persuade individuals to adopt a 
new behavior, a line of recent research has begun investigating the ways that persuasive 
messages influence decision making. People typically have cognitive responses to health 
messages that are considered as supporting thoughts, counter thoughts, or neutral thoughts (Shen 
& Dilard, 2007). This cognitive response is thought to mediate the relationship between message 
and attitude, which then leads to behavior adoption in many motivational health behavior models 
(Shen & Dillard, 2007). Specifically, individual differences in chronic activation of BIS and 
BAS predispose people to the tendency to feel a certain way when exposed to different health 
messages. Indeed, self-reported BIS and BAS were directly correlated with negative and positive 
emotional responses to messages, respectively, in a previous study (Dillard & Peck, 2001). 
Furthermore, individual differences in BIS and BAS are thought to reflect a tendency for 
avoidance- and approach-related behaviors, respectively. 
In order to further elucidate the effects of individual differences on health behaviors, 
Dillard & Anderson (2004) investigated the ways that fear persuaded 361 participants to obtain a 
free influenza vaccination after reading a health message describing the dangers of influenza. 
Researchers assessed participants’ fear arousal levels before and after presenting the fear- 
arousing message, and after presenting a message describing the way to obtain an influenza 
vaccination. Main results indicated that BIS was significantly and positively associated with fear 
arousal before and after presentation of the fear-arousing message, and also with peak fear 
intensity. BAS scores were not associated with fear measures, as predicted. Increases in fear and 
fear intensity positively influenced persuasion of participants to express their intent to obtain an
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influenza vaccination. This study highlights the importance of individual differences in 
perception of negatively valenced health information, as higher BIS scores were associated with 
differences in perception of fear across time of reading the health message components (Dillard 
& Anderson, 2004). 
 
Lauriola, Russo, Lucidi, Violani, & Levin (2005) investigated the role of personality in 
positively and negatively framed risky health decisions, including the BIS and BAS elements of 
RST, in order to fill the gap between behavioral decision models and message framing. Messages 
were framed according to attribute-framing (evaluation of a given attribute differs based on 
describing it in positive or negative terms), goal-framing (persuasive message’s appeal differs 
based on describing benefits of attaining or consequences of not attaining a goal), and risky 
choice-framing (choice made differs based on risk level) procedures as a repeated factor, with 
half of the participants receiving a prevention vignette and the other half receiving the promotion 
vignette. Overall results indicated that individual differences in personality and health-related 
tendencies explained 22% of message appeal variance in the prevention focus condition, but only 
6% in the promotion focus condition. Specific findings related to RST included that BAS 
subscales (especially BAS-Fun Seeking) were positive predictors of risk-taking in negative 
frame conditions (Lauriola et al., 2005). 
Shen and Dillard (2007) also investigated the influence of RST elements and message 
framing on the processing of persuasive health messages, with a specific focus on advantage 
framing effects where messages differed on goal congruence. Framing effects were observed, as 
advantage framing resulted in stronger positive emotions, while disadvantage framing resulted in 
stronger negative emotions. An interaction was observed between BIS/BAS and framing on
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cognitive response. BIS correlated positively with cognition in the disadvantage frame condition 
while BAS correlated positively with cognition in the advantage frame (Shen & Dillard, 2007). 
Summary and Implications 
In summary, considering health behavior through a perspective consistent with individual 
differences research has already uncovered many avenues for further exploration regarding 
adherence. Particularly useful are frameworks that allow for concurrent delineation of underlying 
neural mechanisms that influence immediate orientation to affective and novel stimuli, 
subsequent cognitive appraisals of the stimuli, and ultimate formations of behavioral intentions, 
which have been found to be predictive of adherence behaviors across motivation health 
behavior models. RST provides such a framework, and its facets have been shown to predict 
neurophysiological, cognitive, and behavioral responses that have useful applications for 
predicting adherence behaviors and devising practical, tailored approaches for adherence 
enhancement. Especially relevant to the current study were findings indicating from Shen and 
Dillard (2007) that message framing can evoke varying levels of affect, which can be tailored to 
appeal to individual differences in BIS or BAS, perhaps to an extent that would increase 
behavioral intentions and subsequent adherence behaviors. As the present study seeks to explore 
how these factors relate to a patient’s experience of receiving a specific health diagnosis of OSA 
and CPAP treatment recommendations, the next chapter will focus on available research on OSA 
and CPAP adherence.
 CHAPTER IV: NONADHERENCE FACTORS OF OBSTRUCTIVE SLEEP APNEA 
TREATMENTS 
Obstructive Sleep Apnea (OSA) is a common sleep disorder characterized by at least five 
respiratory events caused by obstructions of the upper airway during sleep, due to collapse of the 
dilator muscles and soft tissues of the pharyngeal wall (ICSD-2, 2005; Olsen, Smith, & Oei, 
2008). The respiratory events and the arousals from sleep needed to reinstate breathing result in 
two main clinical concerns, which are hypoxia of the brain and heart and sleep fragmentation 
(Aloia et al., 2003; Gale & Hopkins, 2004). One of the chief concerns reported by patients is 
inability to gain restorative sleep due to disruptions in the sleep cycle architecture. Concurrent 
OSA symptoms include daytime sleepiness, snoring, and choking arousals from sleep. Having 
OSA increases risk of hypertension (Coughlin, Mawdsley, Mugarza, Wilding, & Calverley, 
2007; ICSD-2, 2005), Type II diabetes, and stroke (Malhotra & White, 2002), and is associated 
with cognitive impairments (Aloia et al., 2003; Malhotra & White, 2002; Watson, Loveless, 
Highsmith, Lehockey, & Everhart, 2013) and comorbid anxiety and depression (ICSD-2, 2005; 
Parish & Lying, 2003; Patel, White, Lamhotra, Stanchina, & Ayas, 2003; Veale, Poussin, Benes, 
Pepin, & Levy, 2002). It also places patients at risk of early mortality (Marshal, Wong, Liu, 
Cullen, Knuiman, and Grunstein, 2008; Punjabi et al., 2009; Young et al., 2008). 
OSA sleep disruptions are either apneas (cessations in breathing lasting at least 10 
seconds) or hypopneas (at least a 50% reduction in airflow for at least 10 seconds, associated 
with 3% oxygen desaturation from baseline, or at least a 30% reduction in airflow for at least 10 
seconds associated with a 4% oxygen desaturation from baseline) (Lee, Nagubadi, Kryger, & 
Mokhlesi, 2008; Mbata & Chukwukw, 2012). The severity of OSA is determined from the 
number of these events per hour of sleep, and is called the apnea-hypopnea index (AHI). A
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patient with an AHI between 5-14 is considered to suffer from mild OSA, while moderate OSA 
is defined as an AHI between 15-30, and severe OSA indicated by an AHI greater than 30 (Lee 
et al., 2008). 
Approximately 20% of adults suffer from mild OSA, and 1 in 15 adults are estimated to 
suffer from moderate to severe OSA. Prevalence rates increase with age until they plateau 
around 65 years (Young, Skatrud, & Peppard, 2004). Men were found to be more likely to suffer 
from OSA than women, but women were more likely to have poorer outcomes. Excess body 
weight was also found to be associated with increased risk of OSA (Lee et al., 2008). In addition 
to OSA being a risk factor of other health conditions, often people who are diagnosed with OSA 
already have co-occurring chronic health conditions, especially cardiovascular and metabolic 
concerns (Becker et al., 2003; Einhorn et al., 2007; Foster et al., 2009; Gami et al., 2004 Logan 
et al., 2001; Oldenburg et al., 2007; Sjöström et al., 2002). 
 
Patients who suffer from OSA are typically prescribed one of the following apparatuses: 
CPAP (continuous positive airway pressure), BiPAP (Bilevel Positive Airway Pressure), or 
APAP (Automatic Positive Airway Pressure). CPAP utilizes continuous and direct air pressure to 
keep the airway unobstructed, delivered from the air compressor-like CPAP machine through a 
mask placed over the nose and/or mouth. BiPAP provides two levels of pressure and three 
different modes within the patient’s control of adjustment. APAP continuously monitors the 
patient’s breathing using pressure sensors, and adjusts the pressure to accommodate the patient’s 
breathing (e.g., increases the pressure when the patient is unable to breathe) (Moran, Highsmith, 
Lehockey, & Everhart, 2012). These treatments reduce the risk of adverse outcomes by 
preventing the collapse of the upper airway during sleep. CPAP has been shown to decrease 
daytime sleepiness, improve neurocognitive functioning, decrease hypertension, and improve
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quality of life (Budhiraja et al., 2007; Kryger et al., 2000). Notably, adherence to CPAP has been 
shown to significantly reduce mortality risk for individuals with heart failure (Kaneko et al., 
2003; Kasai et al., 2008), and to improve insulin sensitivity and blood glucose control (Babu, 
Herdegen, Fogelfeld, Shott, & Mazzone, 2005; Harsch et al., 2004). In addition to improved 
physical health outcomes, CPAP treatment has been associated with improved marital 
satisfaction, increased bed-sharing, increased embraces, and reduced disagreements between 
partners (McFadyen, Espie, McArdle, Douglas, & Engleman, 2001). 
Unfortunately, adherence rates to CPAP treatment are suboptimal, with 15-30% of 
patients rejecting CPAP treatment from the outset of diagnosis (Collard, Peiters, Aubert, 
Delguste, & Rodenstein, 1997), 25-50% of patients initially accepting treatment but failing to 
demonstrate optimal adherence (Zozula & Rosen, 2001), and 25% of patients ultimately stopping 
use by the third year of treatment (Engleman & Wild, 2003). The most common reasons for 
discontinuing CPAP treatment in one study included therapy-related factors, such as mask 
discomfort, nasal dryness, congestion, difficulty exhaling, sore ribs, and air swallowing 
(Berthon-Jones, Lawrence, Sullivan, & Grunstein, 1996). Three recent meta-analyses 
investigating adherence across different pressure-adjusting treatment modalities indicated 
generally no evidence for increased adherence, except for a significant 11-13 min/night increase 
for APAP, which is only prescribed to selected patients (Bakker & Marshall, 2012; Ip, 
D’Ambrosio, Patel, Obadan, Kitsios, Chung, et al., 2012; Smith & Lasserson, 2009). Despite 
these mechanical advances in CPAP treatment devices made to address adverse side effects, 
adherence rates have not improved suggesting that there are additional underlying theoretical 
mechanisms related to CPAP adherence (Olsen, Smith, & Oei, 2008).
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In addition to these biomedical factors, psychosocial factors such as social undesirability 
of apparatus use while in the company of one’s partner, either due to embarrassment of having to 
use the machine or due to partner reports of dissatisfaction with machine noise, were reported as 
barriers to successful CPAP adherence (Zozula & Rosen, 2001). This could relate to perceived 
lack of social support, and speaks to the influence of factors within the social domain of the 
biopsychosocial model (Lewis, Seale, Bartle, Watkins, & Ebden, 2004). CPAP adherence has 
also been studied using motivational health behavior models, such as the HBM. 
The HBM has been utilized to investigate these underlying mechanisms. Sage, Southcott, 
 
& Brown (2001) adapted CPAP questionnaire items to assess HBM constructs in 40 patients 
with OSA after initial CPAP titration. Adherence was measured for one month thereafter. 
Perceived benefits of using CPAP were positively associated with adherence. Self-efficacy in 
ability to overcome adherence obstacles was also positively associated to adherence. Concern 
about barriers to CPAP adherence was inversely associated with adherence rates. These 
subjective patient factors were overall more predictive of CPAP adherence than were objective 
severity measures (Sage, Southcott, & Brown, 2001). 
Similar findings emerged from a more recent study on nonadherence in OSA. Olsen, 
Smith, Oei, & Douglas (2008) conducted the same basic procedures as Sage, Southcott, & 
Brown (2001), but provided the CPAP questionnaire to patients after receiving an OSA diagnosis 
but before starting CPAP, hoping to explain high rates of initial resistance to CPAP. Assessing 
patients’ beliefs before starting CPAP allowed researchers to gain insight into patient 
motivations and intentions before patients gained knowledge of side effects to CPAP treatment. 
Patient beliefs regarding expectancy of effectiveness of CPAP predicted adherence at four
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months. Other predictors of adherence consistent with the HBM included low perceived risk and 
high perceived functional limitations associated with CPAP nonadherence (Olsen et al., 2008). 
Poulet, Veale, Arnol, Levy, Pepin, and Tyrell (2009) similarly measured health beliefs of 
 
OSA and CPAP via the Apnea Beliefs Scale in 122 OSA patients one month prior and one 
month after initiating CPAP. A decision-tree analysis identified three baseline factors including 
the use of responses to the Apnea Beliefs Scale to correctly predict 85.7% of nonadherence. 
Golay and colleagues (2006) were interested in designing and testing a workshop-based 
educational intervention to increase CPAP adherence in 35 patients with OSA. Workshops 
consisted of groups of three to four patients during patients’ 36 hour stay at a hospital, at which 
time various providers would engage the patients in education regarding the purpose of CPAP 
treatment, how to use the apparatus, the benefits and disadvantages of daily CPAP use, and 
discussions with family members regarding the nature of CPAP treatment. Results indicated no 
significant change in CPAP adherence after three months, but subjective sleepiness was 
significantly improved as indicated via self-reported symptoms on the Epworth Sleepiness Scale 
three months later. In a more recent study investigating the influence of CPAP and OSA 
knowledge on adherence, Trupp, Corwin, and Ahijevych (2011) conducted a randomized 
controlled trial of educational message framing (i.e., negative and positive frames) to enhance 
CPAP adherence in 70 patients with OSA and cardiovascular disease. CPAP use was greater in 
the group who received the negative message frame at thirty days. Furthermore, baseline self- 
efficacy scores were greater in those patients who used CPAP the first night after receiving 
health recommendations. 
Personality variables have also been considered as possible predictors of CPAP 
 
adherence. In one study using the Minnesota Multiphasic Personality Inventory- 2
nd 
Edition
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(MMPI-2), self-reported CPAP adherence was associated with lower scores on the 
Hypochondriasis (measures somatic concerns) and Depression (measures depression associated 
with personal worth, withdrawal, psychomotor retardation, and other depressive symptoms) 
clinical scales. It could not be determined whether lower scores on these scales predicted 
adherence behavior or if adherence behavior alleviated potential elevations on these scales 
(Chervin, Theut, Bassetti, & Aldrich, 1997). Consistent with studies of nonadherence to other 
treatment regimens as described in the previous section, neuroticism was found to be a 
significant predictor of nonadherence (Moran, Everhart, Davis, & Wuensch, 2010). There is 
variability in the predictive utility of neuroticism in the literature, with Drake (2003) not finding 
a significant association between this trait and nonadherence. In addition to neuroticism, Moran 
et al. (2010) identified BIS as the strongest predictor of nonadherence to CPAP among the 
variables they entered into logistic and multiple regression models. This study did not find any 
coping strategies as measured in the Ways of Coping Questionnaire (Lundqvist & Ahlstrom, 
2006) to be significant predictors of CPAP nonadherence, although previous research 
demonstrated that Planful Problem Solving and Confrontive Coping subscales of the Active 
Coping scale to be positively associated with adherence (Stepnowsky et al., 2002). 
Purpose and Research Questions 
 
The current study examined individual differences associated with the phenomenological 
experience of receiving health information. This study addressed questions regarding 
psychological and neurophysiological predictors of treatment adherence and behavioral 
intentions to participate in treatment. Using RST to investigate potential mechanisms underlying 
the person-centered constructs shared across leading theories on health behaviors, two studies
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(one laboratory experiment and one clinical study) that answer the following research questions 
were completed: 
 
 
 
Question 1. Does RST predict behavioral intentions and/or behavior? This question was 
addressed in the following ways: 
Study One: 
 
It was hypothesized that BIS would be positively associated with behavioral intentions to 
adhere to the disadvantage-framed message in the experimental laboratory study due to its 
association with negative emotion and avoidance-related behaviors. BAS subscales were 
hypothesized to be positively associated with behavioral intentions to the advantage-framed 
message due to their associations with positive emotion and approach-related behaviors. 
Study Two: 
 
BIS was found to be a significant predictor of nonadherence behavior in previous 
research (Moran et al., 2010), thus, it was hypothesized that BIS would again predict treatment 
nonadherence behavior in a convenience sample of OSA patients. 
 
 
 
Question 2. Does P300 ERP predict behavioral intentions according to RST? This question was 
addressed in the following ways: 
Study One: 
 
As previously explained, the P300 is an event-related potential that is particularly 
sensitive to novel incoming information. According to leading health behavior models, 
subjective beliefs are central to a patient’s decision to engage in adherence behaviors. Eliciting 
the P300 through an active, affective oddball paradigm will allow researchers to investigate the
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importance of tailoring health messages to appeal to the emotional tendencies of patients given 
their predisposing BIS and BAS trait levels. Differences in P300 amplitudes will provide further 
clarification regarding patients’ immediate perceptions of novel incoming health information at 
the neurophysiological level. 
It was hypothesized that higher BAS scores would be associated with larger P300 
amplitudes during negative oddball stimuli presentations and overall higher behavioral intentions 
scores. It was also hypothesized that higher BIS scores would be associated with larger P300 
amplitudes during positive oddball stimuli presentations and overall lower behavioral intentions 
scores. 
 
 
 
Question 3. Do resting frontal asymmetry correlates replicate previous findings related to RST, 
and do these predict behavioral intentions and/or behavior? 
Studies One and Two: 
 
It was hypothesized that higher BAS scores would be associated with greater relative left 
frontal activity while higher BIS scores would be associated with greater relative right frontal 
activity. 
Study One: 
 
It was hypothesized that greater relative left frontal activity would be associated with 
greater behavioral intentions to adhere to the advantage-framed message, while greater relative 
right frontal activity would be associated with higher behavioral intentions to adhere to the 
disadvantage-framed message. 
Study Two:
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It was hypothesized that greater relative left frontal activity would be associated with 
greater adherence behavior in the clinical sample, while greater relative right frontal activity 
would be associated with lower adherence behavior.
 CHAPTER V: STUDY ONE 
 
Method 
 
Participants. Based on a priori power analysis to detect medium effects with 80% power 
using GPower 3.1, 87 right-handed volunteers aged 18 years and older from East Carolina 
University were recruited using the undergraduate psychology participant pool during fall and 
spring semesters, with some students recruited during the summer semester (Appendix D). All 
participants gave informed consent to the protocol, which was approved by the East Carolina 
University and Medical Center Institutional Review Board (Appendix B & J). Four participants 
were excluded from analyses because they were receiving psychopharmacological treatment for 
depression, three were excluded for history of significant head trauma or other neurological 
history, and three others were excluded because they fell asleep during the experimental EEG 
procedures. Once adjusted for exclusionary criteria, 77 participants were included in statistical 
analyses. Of these participants, 38 were women and 39 were men. The mean age of participants 
was 19.08 years (SD = 1.19), and the mean level of education achieved by participants was 12.90 
years (SD = 1.01). All participants included in statistical analyses had normal or corrected-to- 
normal vision and no prior significant neurological or psychiatric history. Exclusionary criteria 
for study one also included current diagnosis of obstructive sleep apnea (OSA), as part of the 
experimental procedure entailed imagining receiving such a diagnosis. 
Materials. Participants completed several self-report measures before and during the 
experimental procedure to assess exclusionary criteria and factors of interest. 
Assessing exclusionary criteria. The Lateral Preference Inventory was administered to 
assess for handedness and other features of lateral preference to control for possible resting EEG 
asymmetry confounds (i.e., eye, ear, leg) (Coren, Proac, & Duncan, 1979). Participants also
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completed a general information survey, assessing demographic (age, sex, education level) and 
medical history variables (history of neurological or psychiatric conditions, current 
psychopharmacological treatment) (Appendix E). 
Measuring behavioral inhibition and behavioral activation. Carver and White’s (1994) 
BIS/BAS scales were completed by the participants as a way to measure self-reported behavioral 
inhibition and behavioral activation of each participant. While the BIS/BAS scales have 
reasonable support for their construct validity and four-factor structure measured via one BIS 
subscale and three BAS subscales (BAS Drive, BAS Reward Responsiveness, BAS Fun Seeking; 
alphas ranging from .66-.76, with two-month test-retest reliabilities ranging from r .59-.69; 
Carver & White, 1994), there has been some criticism of the BAS-Reward Responsiveness 
subscale (Cogswell, Alloy, van Dulmen, & Fresco, 2006; Gomez, Cooper, & Gomez, 2005). The 
main criticism was that BAS Reward Responsiveness was positively correlated with BIS and 
independent from the other BAS subscales, which is not reflective of RST, and this subscale’s 
items were only effective in representing the construct at very low to just around the mean trait 
levels. Additionally, the BIS facet as it is currently defined within the updated version of RST 
has not been thoroughly tested. Given these limitations, the Appetitive Motivation Scale (AMS) 
and the Sensitivity to Punishment Questionnaire (SPQ) were used to approximate these 
constructs more thoroughly. 
The AMS was administered to all participants to investigate features of the BAS related 
to participants’ processing of appetitive stimuli (Jackson & Smillie, 2004). It was developed to 
assess the tendency to approach experiences resulting in rewarding stimuli, with less emphasis 
on impulsive behavior that has been a focus of assessment in other RST measures. Another 
purpose of its development was to return the BAS construct to a one factor structure as opposed
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to breaking it into subscales. The AMS has demonstrated good internal consistency (alpha = .81), 
good convergent validity with other reward-oriented BAS measures (e.g., BAS Drive r = .49, 
BAS Fun Seeking r = .55, BAS Reward Responsiveness r = .22; all significant p < .05), and 
good discriminant validity with low to moderate negative correlations with BIS measures 
 
(Cooper, Smillie, & Jackson, 2008). 
 
The SPQ was administered to all participants in order to best approximate facets of the 
BIS specifically related to punishment sensitivity, but may not fully represent current BIS 
construct as defined in the updated RST (Torrubia et al., 2001). The SPQ demonstrated 
acceptable levels of internal consistency (alphas ranging from .75-.83) and three-month test- 
retest reliabilities (r of .89; Torrubia et al., 2001). 
Measuring coping strategies. The Brief COPE was administered prior to participating in 
the experiment. This measure is a consolidated version of the COPE, which comprises 60 items 
assessing various cognitive and behavioral coping strategies. The Brief COPE is a 28-item 
inventory, consisting of 14 subscales with two items on each scale. The 14 subscales measure 14 
constructs, namely, Active Coping, Planning, Positive Reframing, Acceptance, Humor, Religion, 
Using Emotional Support, Using Instrumental Support, Self-Distraction, Denial, Venting, 
Substance Use, Behavioral Disengagement, and Self-Blame. A unique characteristic of the Brief 
COPE is that it has been designed to accommodate retrospective, concurrent, or dispositional 
formats, allowing researchers flexibility in how they ask each of the questions. This study 
included the following modification to the first statement: “These items deal with ways you’ve 
been coping with the stress in your life since you found out you were diagnosed with obstructive 
sleep apnea.” The Brief COPE has demonstrated acceptable internal reliability (alphas ranging
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from .50 [Venting subscale] -.90 [Substance Use subscale]), with a factor structure that was 
generally consistent with the full COPE (Carver, 1997). 
Simulation study stimuli and subjective response measures. During the experimental 
phase of Study One, participants were asked to pretend that they had just received a diagnosis of 
a chronic health condition, namely, OSA. They subsequently viewed two separate health 
information videos describing treatment guidelines that were advantage-framed or disadvantage- 
framed to elicit relatively different levels (positive and negative) of affect (Shen & Dillard, 
2007). They then indicated their affective responses to the messages by completing the Self- 
Assessment Manikin (SAM), a tool for rating subjective emotion (Lang, 1980), which has been 
shown to be an effective instrument for measuring existing feeling states (Bradley & Lang, 
1994). The SAM assesses three components of emotion, namely valence, arousal, and control, 
using a nonverbal, visual response system where participants choose which picture best 
represents how they feel in response to a given stimulus (Bradley & Lang, 1994). Participants 
indicated their level of behavioral intentions by answering the following item: “Please indicate 
the likelihood that you would follow the physician’s recommendations.” The response format 
was on a scale from 0% (certain that I will not adhere) to 100% (certain that I will adhere) 
(Dillard & Anderson, 2004). 
OSA was chosen due to the complex nature of treatment recommendations and the health 
consequences associated with nonadherence behaviors. As the second study focuses on a sample 
of OSA patients and their adherence behaviors, choosing OSA as the disease state for simulation 
in Study One allows for the potential to study mechanisms that may be treatment-specific (e.g., 
presentation of the CPAP machine as a visual stimulus may provoke affective activation unique 
to OSA patients). Furthermore, one of the aims of this study is to better understand the potential
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underlying mechanisms driving adherence behaviors in the clinical sample; findings from this 
simulation study within a lab environment can control and test variables of interest that are 
otherwise impossible to test in a clinical setting. Such variables include novelty of receiving a 
health diagnosis, real-time ratings of affective responses to incoming affective health 
information, and careful tailoring of affective health messages to include the same content while 
using different frames. 
Prior to use in Study One, videos underwent pilot testing on Qualtrics to ensure the two 
conditions elicited significant differences in affect. All participants gave informed consent to the 
protocol, which was approved by the East Carolina University and Medical Center Institutional 
Review Board (Appendix A & I). After viewing each video, 133 undergraduate participants 
completed the SAM. Pilot test results demonstrated significant differences of elicited affect 
across each facet of subjective emotion measured by the SAM. Paired samples t-tests indicated 
that participants rated the advantage-framed message as eliciting significantly more positive 
affect (M = 5.97, SD = 1.693) than the disadvantage-framed message (M = 3.95, SD = 1.810), 
t(122) = 10.456, p < 0.001, d = 1.333, 95% CI [1.031, 1.632]. Similarly, they rated the 
advantage-framed message as eliciting significantly higher levels of control (M = 5.41, SD = 
 
2.100) than the disadvantage-framed message (M = 4.39, SD = 2.231), t(122) = 5.805, p < 0.001, 
d = 0.740, 95% CI [0.472, 1.006]. The disadvantage-framed message elicited significantly higher 
levels of arousal (M = 4.46, SD = 1.852) than the advantage-framed message (M = 3.95, SD = 
1.894), t(122) = 2.536, p = 0.012, d = 0.323, 95% CI [0.0700, 0.576]. Results from pilot testing 
indicated that these simulation videos were appropriate to use in the present study. 
EEG study equipment and stimuli. The control and presentation of the experimental 
 
stimuli and recording of participants’ responses was managed with SCAN 4.4 software
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(Compumedics Neuroscan, El Paso, TX). Stimuli consisted of two types of pictures (positive, 
negative) selected from the IAPS, which are matched for valence and arousal (Bradley & Lang, 
2007).  All items were matched for luminance and size. Event related potentials were recorded 
during stimuli presentation throughout the duration of the task. 
Active affective oddball paradigm. Participants completed a visual oddball paradigm 
task. As previously explained, an oddball task consists of the presentation of frequent and 
oddball stimuli. In this experiment, stimuli were chosen from the IAPS based on valence, and 
were arranged into the following two conditions for presentation: positive-standard, negative- 
target (PS/NT) and negative-standard, positive-target (NS/PT). The order of condition 
presentation was counterbalanced across participants. Participants were asked to fixate on a 
centered “+” symbol on the computer monitor before the beginning of each condition. 
Participants were asked to silently count the number of target stimuli presentations in each 
condition. Presentation of stimuli was pseudorandom in order to meet criteria that an odd number 
of standard stimulus presentations were always between target stimulus presentations and that 
target stimuli were never presented in series (De Pascalis et al., 2004). For each trial, 125 
standard and 25 target stimuli presentations occurred, with a variable interstimulus interval 
between 900 and 1100ms and stimulus duration of 500ms. 
Procedures. Participants were tested in the Cognitive Neuroscience Laboratory located 
within the Department of Psychology at East Carolina University. Procedures for Study One are 
summarized in Figure 1. Prior to participation, informed consent forms approved by the 
University and Medical Center Institutional Review Board of East Carolina University were 
reviewed orally with each participant and signed (Appendix B). Adherence to the “Ethical 
Principles of Psychologists and Code of Conduct” was kept with all participants in this study
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(American Psychological Association, 2002). Once consent was established, participants 
completed self-report inventories and health message simulation tasks, acclimated to EEG 
recording procedures, and were given written instructions for the oddball paradigm task. 
Procedures for EEG analysis were adapted from Everhart and Demaree (2003). 
Participants were seated in an electrically shielded room in a comfortable reclining chair and 
fitted with a lycra electrode cap (Electro-Cap International, Inc.). Electrodes were arranged 
according to the 10-20 international system (Jasper, 1958). EEG data were recorded from 32 
active electrode sites using linked ears (A1 and A2) as a reference (monopolar montage). 
Electrode placement included Frontal: F3, F4, F7, F8; Central: Cz, C3, C4; Temporal: T3, T4, 
T5, T6; Parietal: Pz, P3, P4; and Occipital: O1, O2. In addition, electrodes were placed on the 
outer cantus of each eye so that eye movement recordings could be obtained. Electrode 
impedance was maintained below 5000 holms and checked at the beginning and end of the 
experimental session. Eye movement recordings were used to correct for the presence of eye 
movement artifact in the ERPs and to determine which trials should be excluded from averaging. 
Individual trials that contain excessive artifact associated with body and eye movement were 
excluded during off-line processing and prior to averaging. The EEG and eye movements were 
recorded with a bandpass of 1 and 100 Hz and a sensitivity of 7.5 µV/mm for EEG recordings. 
The EEG signal was amplified and converted on line to digital using a NeuroScan 32-channel PC 
 
based EEG/Evoked potential brain mapping system. A high-pass filter was used to eliminate 
slow wave frequencies that were less than 0.2 Hz. A 60 Hz notch filter was used to eliminate 60 
Hz line noise. Artifact reduction was completed prior to computing grand averages for EEG and 
P300 data. Data were stored and analyzed on a PC Pentium Computer. The EEG data were 
converted on line for display, storage, and analysis (Everhart & Demaree, 2003).
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Once they completed informed consent procedures and expressed understanding of  all 
experimental procedures, participants engaged in two phases of research that were 
counterbalanced to control for order effects. One phase comprised tasks completed within the 
EEG booth. During this phase, participants’ baseline EEG were recorded according to 
procedures adapted from Davidson (1988), including eight minutes of baseline recording 
alternating between eyes open and eyes closed conditions, followed by completion of two 
conditions of the oddball paradigm task [positive-standard, negative-target (PS/NT) and 
negative-standard, positive-target (NS/PT)]. The other phase of research comprised tasks 
completed outside of the EEG booth in the Cognitive Neuroscience Laboratory. Tasks included 
completion of self-report inventories assessing variables of interest, followed by presentations of 
the two video health messages, SAM ratings, and indication of behavioral intentions. 
Presentation order of the advantage-framed and disadvantage-framed health messages was 
counterbalanced in order to control for order effects. 
After completion of the study, P300 responses were identified by visual inspection as the 
most positive peak occurring between 250ms and 500ms after stimulus presentation (Coles & 
Rugg, 1995). Separate grand averages for all data were created (Figures 2-4). Event related 
potentials were averaged across participants for emotional valence and stimulus duration.
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Figure 1. Summary of Study One procedures. 
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Figure 2. Grand averages of P300 responses to nontarget, positive target, and negative target 
stimuli presentations at electrode FCz.
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Figure 3. Grand averages of P300 responses to nontarget, positive target, and negative target 
stimuli presentations at electrode Cz. 
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Figure 4. Grand averages of P300 responses to nontarget, positive target, and negative target 
stimuli presentations at electrode Fz.
53  
Statistical analyses. Primary analyses performed were multiple regression analyses 
predicting behavioral intentions scores from responses to the BIS/BAS scales, AMS, SPQ, Brief 
COPE, SAM, P300 amplitudes, and resting frontal asymmetry scores. Correlation analyses were 
also conducted between trait variables and EEG baseline asymmetry scores to determine if 
previous findings in the individual differences literature were replicated. Alpha level was set at 
.05 in tests of statistical significance. Data analyses were performed using SPSS version 17.0. 
 
Results 
 
Multiple regression analyses were employed to test the hypothesis that treatment 
adherence behavioral intentions would be predicted from self-reported individual differences on 
BIS and BAS subscales, AMS, SPQ, Brief COPE, SAM responses, P300 amplitudes, and resting 
frontal asymmetry scores. Prior to conducting separate multiple regression analyses for each 
health message condition (advantage-framed and disadvantage-framed), Pearson correlations 
between predictor variables and behavioral intentions scores for each health message condition 
were investigated. Only those predictors that were significant at the .10 level were retained in 
subsequent models. The following variables were dropped prior to both multiple regression 
analyses: BAS Drive, BAS Reward Responsiveness, BAS Fun Seeking, Appetitive Motivation 
Scale, Sensitivity to Punishment Questionnaire, Brief Cope (BC): Planning, BC: Positive 
Reframe, BC: Acceptance, BC: Religion, BC: Emotional Support, BC: Instrumental Support, 
BC: Self-distraction, BC: Denial, BC: Venting, BC: Substance Use, BC: Disengagement, BC: 
 
Self-blame, SAM Arousal Responses to Advantage-Framed Message, SAM Valence and Arousal 
Responses to Disadvantage-Framed Message, Baseline Asymmetry Conditions (Eyes Open 1-2, 
Eyes Closed 1-2, 4), and all P300 amplitudes. Correlation coefficients for behavioral intentions 
responses to each health message condition and self-reported predictor variables are displayed in
54  
Table 1. Correlation coefficients for behavioral intentions responses to each health message 
condition and EEG and ERP predictor variables are displayed in Table 2. 
Table 1. Pearson correlations for behavioral intentions responses to each health message 
condition and self-reported predictor variables. 
 Behavioral Intentions for Each 
Health Message Condition 
Self-Report Predictor Variable AdvBI DisBI 
RST Variables: 
BIS .221* .271** 
BAS Drive .063 .043 
BAS Reward Responsiveness -.020 -.015 
BAS Fun Seeking .075 .166 
Appetitive Motivation Scale -.170 .000 
Sensitivity to Punishment Questionnaire -.078 .013 
Brief COPE Subscales: 
Active .201* .106 
Planning .052 .025 
Positive Reframe .051 .083 
Acceptance .173 .085 
Humor -.192* -.197* 
Religion .068 -.004 
Emotional Support .077 .111 
Instrumental Support .114 .099 
Self-distraction -.062 -.118 
Denial .026 .000 
Venting -.075 -.057 
Substance Use -.090 -.136 
Disengagement .055 .058 
Self-blame -.129 -.049 
SAM Responses to Advantage-Framed Message 
Valence .276** .153 
Arousal -.025 .021 
Control .270** .305*** 
SAM Responses to Disadvantage-Framed Message 
Valence .064 .063 
Arousal -.050 -.079 
Control .157 .240** 
*** Correlation is significant at the 0.01 level (2-tailed) 
**Correlation is significant at the 0.05 level (2-tailed) 
*p value of correlation is at the 0.10 level (2-tailed)
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Table 2. Pearson coefficients for behavioral intentions responses to each health message 
condition and EEG and ERP predictor variables. 
 Behavioral Intentions for Each Health 
Message Condition 
Electrophysiological Predictor Variable AdvBI DisBI 
Baseline EEG Variables: 
Eyes Open 1 (EO1) -.038 -.069 
Eyes Open 2 (EO2) .010 -.081 
Eyes Open 3 (EO3) -.167 -.197* 
Eyes Open 4 (EO4) -.209* -.222* 
Eyes Closed 1 (EC1) -.034 -.086 
Eyes Closed 2 (EC2) -.057 -.133 
Eyes Closed 3 (EC3) -.152 -.252** 
Eyes Closed 4 (EC4) -.057 -.143 
P300 Amplitudes Variables: 
Positive Target at P3 electrode .097 .094 
Positive Target at Pz electrode .082 .079 
Positive Target at P4 electrode .101 .129 
Negative Target at P3 electrode .099 .091 
Negative Target at Pz electrode .082 .001 
Negative Target at P4 electrode .106 .104 
*** Correlation is significant at the 0.01 level (2-tailed) 
**Correlation is significant at the 0.05 level (2-tailed) 
*p value of correlation is at the 0.10 level (2-tailed) 
 
 
 
 
Notably, two significant correlations were found between affective response predictor 
variables and AdvBI. SAM Valence ratings (M = 6.01, SD = 1.805) were significantly, positively 
correlated with AdvBI (M = 88.37, SD = 14.189), r(76) = 0.276, p = 0.016, 95% CI [0.054, 
0.472], indicating that higher SAM Valence ratings in response to the advantage-framed message 
(higher scores reflect positively valenced emotion) were associated with higher behavioral 
intentions to adhere to the advantage-framed health message. SAM Control ratings in response to 
the advantage-framed message (M = 5.21, SD = 1.995) were significantly, positively correlated 
with AdvBI (M = 88.37, SD = 14.189), r(76) = 0.270, p = 0.018, 95% CI [0.048, 0.467], 
indicating that higher SAM Control ratings in response to the advantage-framed message were
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associated with higher behavioral intentions to adhere to the advantage-framed health message. 
 
Four additional correlations were observed between AdvBI and predictor variables that 
did not reach statistical significance, but achieved a p < .10, and were thus included in the 
multiple regression analysis. These included positive correlations between AdvBI (M = 88.37, 
SD = 14.189) and BIS (M = 19.28, SD = 1.705), r(76) = 0.221, p = 0.055, 95% CI [-0.004, 
0.425], and BC: Active (M = 6.09, SD = 1.435), r(76) = 0.201, p = 0.082, 95% CI [-0.025, 
 
0.407], indicating that higher scores on these self-report scales were associated with higher 
behavioral intentions to adhere to the advantage-framed health message. A negative correlation 
was observed between AdvBI (M = 88.37, SD = 14.189) and BC: Humor (M = 4.63, SD = 
1.799), r(76) = -0.192, p = 0.097, 95% CI [-0.400, 0.034],  indicating that higher BC: Humor 
scores were associated with lower behavioral intentions to adhere to the advantage-framed health 
message. Finally, a negative correlation between AdvBI (M = 88.37, SD = 14.189) and EO4 (M 
= 0.148, SD = .270), r(75) = -0.209, p = 0.072, 95% CI [-0.416, 0.018], indicating that greater 
relative left frontal activity was associated with lower behavioral intentions to adhere to the 
advantage-framed health message. 
Four significant correlations were observed between predictor variables and DisBI. A 
significant, positive correlation was observed between DisBI (M = 86.57, SD = 17.613) and BIS 
(M = 19.28, SD = 1.705), r(76) = 0.271, p = 0.018, 95% CI [0.049, 0.467], indicating that higher 
self-reported BIS scores were significantly associated with higher behavioral intentions to adhere 
to the disadvantage-framed health message. Two significant, positive correlations were also 
found between DisBI (M = 86.57, SD = 17.613) and two affective predictor variables: SAM 
Control responses to the advantage-framed message (M = 5.21, SD = 1.995), r(76) = 0.305, p = 
0.007, 95% CI [0.086, 0.496], and SAM Control responses to the disadvantage-framed message
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(M = 4.64, SD = 2.240), r(76) = 0.240, p = 0.037, 95% CI [0.016, 0.441]. These correlations 
indicate that higher control responses to both messages were significantly associated with higher 
behavioral intentions to adhere to the disadvantage-framed health message. A significant 
negative correlation was observed between DisBI (M = 86.57, SD = 17.613) and EC3 (M = 0.155 
 
SD = 0.187), r(75) = -0.271, p = 0.029, 95% CI [-0.469, -0.047], indicating that greater relative 
left frontal activity was significantly associated with lower behavioral intentions to adhere to the 
disadvantage-framed health message. 
Three additional correlations were observed between DisBI and predictor variables that 
did not reach statistical significance, but achieved a p < .10, and were thus included in the 
multiple regression analysis. These included negative correlations between DisBI (M = 86.57, 
SD = 17.613) and two baseline asymmetry measures: EO3 (M = 0.106, SD = 0.234), r(75) = - 
0.197, p = 0.090, 95% CI [-0.405, 0.031],   and EO4 (M = 0.148, SD = 0.270), r(75) = -0.222, p 
 
= 0.056, 95% CI [-0.427, 0.005], indicating that higher relative left frontal activity was 
 
associated with lower behavioral intentions to adhere to the disadvantage-framed health message. 
Another negative correlation was observed between DisBI (M = 86.57, SD = 17.613) and BC: 
Humor (M = 4.63, SD = 1.799), r(76) = -0.197, p = 0.088, 95% CI [-0.404, 0.029], indicating 
that higher scores on this self-report scale were associated with lower behavioral intentions to 
adhere to the disadvantage-framed health message. 
Behavioral intentions for advantage-framed message model. A test of the full multiple 
regression model for behavioral intentions to adhere to the advantage-framed health message 
included BIS, BC: Active, BC: Humor, SAM Valence and Control Responses to Advantage- 
framed message (AdvSAMV and AdvSAMC), and EO4 as predictor variables. The assumptions 
of linearity, independence of errors, homoscedasticity, unusual points, and normality of residuals
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were met. These variables statistically significantly predicted behavioral intention responses to 
the advantage-framed health message, F(6, 68) = 4.431, p = 0.001, R
2 
= 0.281, 95% CI [0.0684, 
0.368]. BC: Humor (p =.020) and AdvSAMV (p =.016) each added statistically significantly to 
the prediction, p < 0.05. BC: Humor had a significant negative regression weight, indicating that 
participants who scored higher on this scale were expected to endorse lower levels of behavioral 
intentions to adhere to the advantage-framed message. AdvSAMV had a significant positive 
regression weight, indicating that participants who rated the advantage-framed message as 
eliciting higher levels of valence (positive direction) were predicted to indicate higher levels of 
behavioral intentions to adhere to the advantage-framed message. All other predictors did not 
significantly add to the prediction, p > 0.05. Regression coefficients and standard errors are 
displayed in Table 3.
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Table 3. Summary of multiple regression analysis for behavioral intentions to adhere to the 
advantage-framed message. 
 
Model Summary 
 
 
Model 
 
 
R 
 
 
R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
 
1 .530
a
 .281 .218 12.550 
a. Predictors: (Constant), EO4FA, BCACTIVE, BCHUMOR, BIS, 
ADVSAMV, ADVSAMC 
b. Dependent Variable: ADVBI 
 
 
ANOVA 
 
 
Model 
Sum of 
Squares 
 
 
df 
 
 
Mean Square 
 
 
F 
 
 
Sig. 
1          Regression 
Residual 
 
Total 
4187.673 6 697.946 4.431 .001
a
 
10709.873 68 157.498   
14897.547 74    
a. Predictors: (Constant), EO4FA, BCACTIVE, BCHUMOR, BIS, ADVSAMV, 
ADVSAMC 
b. Dependent Variable: ADVBI 
 
 
Coefficients 
 
 
 
 
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
 
 
 
 
t 
 
 
 
 
Sig. 
95% Confidence 
Interval for B 
 
Correlations 
 
 
B 
Std. 
Error 
 
Beta 
Lower 
Bound 
Upper 
Bound 
Zero- 
order 
 
Partial 
 
Part 
1 (Constant) 
BIS 
BCACTIVE 
BCHUMOR 
ADVSAMV 
ADVSAMC 
EO4FA 
42.830 18.305  2.340 .022 6.304 79.357    
1.524 .879 .183 1.734 .088 -.230 3.279 .212 .206 .178 
1.371 1.034 .139 1.326 .189 -.692 3.434 .189 .159 .136 
-1.948 .819 -.247 -2.380 .020 -3.581 -.315 -.202 -.277 -.245 
2.225 .904 .283 2.460 .016 .420 4.030 .310 .286 .253 
.934 .828 .131 1.129 .263 -.718 2.586 .302 .136 .116 
-9.702 5.520 -.185 -1.758 .083 -20.717 1.313 -.209 -.208 -.181 
a. Dependent Variable: ADVBI
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Behavioral intentions for disadvantage-framed message model. A test of the full 
multiple regression model for behavioral intentions to adhere to the disadvantage-framed health 
message included BIS, BC: Humor, AdvSAMC, SAM Control Responses to Disadvantage- 
framed message (DisSAMC), Baseline Asymmetry during Eyes Open 3 (EO3), EO4, and 
Baseline Asymmetry during Eyes Closed 3 (EC3) as predictor variables. The assumptions of 
linearity, independence of errors, homoscedasticity, unusual points, and normality of residuals 
were met. These variables statistically significantly predicted behavioral intention responses to 
the disadvantage-framed health message, F(7, 67) = 4.252, p = 0.001, R
2 
= 0.308, 95% CI 
 
[0.151, 0.465]. BIS (p = .049), BC: Humor (p =.013) AdvSAMC (p =.022), and EC3 (p = .028) 
each added statistically significantly to the prediction, p < 0.05. BIS, AdvSAMC had significant 
positive regression weights, indicating participants with higher scores on these scales were 
expected to indicate higher behavioral intentions to adhere to the disadvantage-framed message. 
BC: Humor had a significant negative regression weight, indicating participants with lower 
scores on this scale were expected to indicate higher behavioral intentions to adhere to 
disadvantage-framed message. EC3 also had a significant negative regression weight, indicating 
that participants with lower relative left hemisphere baseline cortical activity (i.e., higher right 
hemisphere activity) were expected to indicate higher behavioral intentions to adhere to the 
disadvantage-framed message. All other predictors did not significantly add to the prediction, p > 
 
0.05. Regression coefficients and standard errors are displayed in Table 4.
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Table 4. Summary of multiple regression analysis for behavioral intentions to adhere to the 
disadvantage-framed message. 
 
Model Summary 
 
 
 
Model 
 
 
R 
 
 
R Square 
 
Adjusted R 
Square 
Std. Error of 
the Estimate 
 
1 .555
a
 .308 .235 15.403 
a. Predictors: (Constant), EC3FA, BIS, BCHUMOR, 
ADVSAMCONTROL, EO3FA, EO4FA, DISSAMCONTROL 
b. Dependent Variable: DISBI 
 
 
ANOVA 
 
 
Model 
Sum of 
Squares 
 
 
df 
 
 
Mean Square 
 
 
F 
 
 
Sig. 
1          Regression 
 
Residual 
Total 
7061.210 7 1008.744 4.252 .001
a
 
15895.136 67 237.241   
22956.347 74    
a. Predictors: (Constant), EC3FA, BIS, BCHUMOR, ADVSAMCONTROL, 
EO3FA, EO4FA, DISSAMCONTROL 
b. Dependent Variable: DISBI 
 
 
Coefficients 
 
 
 
 
 
 
Model 
 
Unstandardized 
Coefficients 
 
Standardized 
Coefficients 
 
 
 
 
 
t 
 
 
 
 
 
Sig. 
95.0% 
Confidence 
Interval for B 
 
 
 
Correlations 
 
 
B 
Std. 
Error 
 
Beta 
Lower 
Bound 
Upper 
Bound 
Zero- 
order 
 
Partial 
 
Part 
1 (Constant) 
BIS 
BCHUMOR 
ADVSAMC 
DISSAMC 
EO3FA 
EO4FA 
EC3FA 
45.671 21.064  2.168 .034 3.627 87.716    
2.166 1.081 .210 2.004 .049 .009 4.323 .264 .238 .204 
-2.617 1.030 -.267 -2.541 .013 -4.673 -.562 -.206 -.296 -.258 
3.046 1.298 .345 2.347 .022 .455 5.638 .336 .276 .239 
-.022 1.166 -.003 -.019 .985 -2.350 2.306 .261 -.002 -.002 
-6.598 9.307 -.088 -.709 .481 -25.176 11.979 -.197 -.086 -.072 
1.935 8.162 .030 .237 .813 -14.355 18.226 -.222 .029 .024 
-26.523 11.816 -.281 -2.245 .028 -50.108 -2.938 -.252 -.264 -.228 
a. Dependent Variable: DISBI
62  
Differences observed across health message conditions. In order to investigate 
potential differential effects of message-framing on behavioral intentions, Wilcoxon signed-rank 
test was performed across participants’ behavioral intentions to adhere to each health message 
because difference scores between dependent  variables violated assumptions of normality and 
contained valid outliers needed for conducting paired-samples t-test. Of the 76 participants who 
completed the study, 26 participants reported higher behavioral intentions after viewing the 
advantage-framed health message, while 22 participants reported higher behavioral intentions 
after viewing the disadvantage-framed health message. Twenty-eight participants reported no 
differences in behavioral intentions across health message conditions. No statistically significant 
difference was observed between behavioral intentions responses across advantage-framed 
(Median = 92.5% certainty of adhering to treatment recommendations) and disadvantage-framed 
(Median = 93% certainty of adhering to treatment recommendations) health message conditions, 
z = -0.981, p = 0.327. 
Correlation analyses were conducted to investigate potential associations between self- 
reported traits and coping strategies and Self-Assessment Manikin (SAM) responses to each 
health message condition. Several significant correlations were observed from these analyses, 
and results are displayed in Table 5. The only significant association observed between SAM 
affective responses to a health message and a factor within the RST framework was the one 
found between BAS Fun Seeking (M = 12.14, SD = 1.614) and arousal ratings in response to the 
advantage-framed condition (M =3.53, SD = 1.701), r(74) = -.344, p = 0.002, 95% CI [-0.528, - 
0.129]. This finding suggests that people who reported higher levels of this trait also reported 
lower levels of emotional arousal in response to viewing the advantage-framed health message. 
Several significant correlations were observed between Brief COPE subscales and SAM
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responses to health messages. Those who reported higher levels of using Acceptance (M = 5.63, 
 
SD = 1.394) as a coping strategy were also likely to report higher levels of control (M = 5.16, SD 
 
= 2.040) in response to viewing the advantage-framed health message, r(74) = .258, p = 0.024, 
 
95% CI [0.035, 0.456]. Four significant correlations were observed between Brief COPE 
variables and SAM responses to the disadvantage-framed message. Participants endorsing higher 
levels of using Religion (M =4.99, SD = 2.176) as a coping strategy were more likely to report 
negatively valenced (M = 3.71, SD = 1.598) emotion in response to the disadvantage-framed 
message, r(74) = -.231, p = 0.045, 95% CI [-0.433, -0.006]. A significant positive correlation 
was observed between using self-blame (M = 3.95, SD = 1.469) as a coping strategy and arousal 
 
(M = 4.08, SD = 1.839) levels after viewing the disadvantage-framed message, r(74) = .300, p = 
 
0.009, 95% CI [0.0800, 0.492]. A significant negative correlation was observed between 
substance use (M = 2.82, SD = 1.383) as a coping strategy and self-reported feelings of control 
(M = 4.59, SD =2.264) after viewing the disadvantage-framed message, r(74) = -.237, p = 0.039, 
95% CI [-0.438, -0.013]. A significant positive correlation was found between self-blame (M = 
 
3.95, SD =1.469) as a coping strategy and self-reported feelings of control (M = 4.59, SD 
 
=2.264) after viewing the disadvantage-framed message, r(74) = .234, p = 0.042, 95% CI [0.010, 
 
0.436].
64  
Table 5. Pearson correlations between SAM Responses to health messages and self-report RST 
and Brief COPE variables. 
 SAM Responses to 
Advantage-Framed Message 
SAM Responses to 
Disadvantage-Framed 
Message 
 
Self-Report 
Variables 
Valence Arousal Control Valence Arousal Control  
Mean 
 
SD 
BIS -.064 -.143 .151 -.051 .141 .191 19.30 1.705 
BASD .063 -.110 .027 -.184 .198 -.063 12.09 1.406 
BASRR -.065 -.155 -.024 -.069 .027 -.108 14.38 1.532 
BASFS -.087 -.344** .050 -.020 .099 .108 12.14 1.614 
AMS .121 -.189 .204 .189 -.145 .024 13.21 3.255 
SPQ -.206 -.024 -.076 -.055 .114 .035 7.74 4.637 
Active .117 .170 .062 -.095 .027 .060 5.86 1.512 
Planning -.017 .100 .044 -.019 .015 -.003 6.12 1.442 
Positive 
Reframe 
.046 .128 -.017 -.019 .012 -.099 6.38 3.749 
Acceptance .184 .056 .258* .076 .004 .181 5.63 1.394 
Humor .096 -.165 .041 .168 .094 -.046 4.64 1.794 
Religion .172 .135 .003 -.231* .217 -.071 4.99 2.176 
Emotional 
Support 
-.028 .052 .067 -.174 -.048 .063 5.37 2.006 
Instrumental 
Support 
.094 .077 -.026 -.164 -.016 .003 5.38 1.918 
Self- 
distraction 
.102 .150 .080 -.169 .114 -.005 5.61 1.609 
Denial .052 .185 -.027 -.076 .031 -.031 2.83 1.182 
Venting .016 .108 .153 -.053 -.006 .139 3.82 1.116 
Substance 
Use 
-.039 .149 -.089 -.205 .079 -.237* 2.82 1.383 
Disengage- 
ment 
.208 .075 .067 -.105 .042 -.026 3.20 3.559 
Self-blame -.168 .107 .141 .113 .300** .234* 3.95 1.469 
Mean 5.96 3.53 5.16 3.71 4.08 4.59  
SD 1.851 1.701 2.040 1.598 1.839 2.264 
*p < .05; **p < .01
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Correlations between RST factors and EEG asymmetry. In order to investigate the 
hypothesis that high scores on the BIS would be associated with right frontal baseline activity 
while high scores on the BAS would be associated with left frontal baseline activity, an 
asymmetry score (Right-Left) for alpha power (8-12 Hz) was calculated. Frontal asymmetry 
scores were calculated for overall alpha power by:1) taking the natural log of the alpha power 
scores at each electrode, and 2) subtracting left alpha power scores from right alpha power scores 
at frontal electrodes (ln[alpha power at F4 electrode] – ln[alpha power at F3 electrode]). The 
inverse of this asymmetry score is believed to represent increased brain activity, thus negative 
scores reflect greater relative right hemisphere EEG activity, and positive scores reflect greater 
relative left activity (Davidson, 1988). Correlation analyses for BIS and BAS scores with the 
asymmetry scores were then conducted and results are presented in Tables 6-7. 
One significant correlation was observed between EC1 (M = .162 microvolts, SD = .203) 
 
and SPQ (M = 7.74, SD = 4.637), r(74) = 0.243, p = 0.034, 95% CI [0.019, 0.444], indicating 
 
that higher SPQ trait values were associated with greater relative left frontal baseline activity. As 
 
SPQ is thought to be related to the BIS trait, this finding does not support the hypothesis that 
BIS-related traits would be associated with greater relative right frontal baseline activity as has 
been observed in previous research. No other significant correlations were observed between 
alpha asymmetry scores and variables of interest.
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Table 6. Correlation matrix showing relationships between BIS Total, BAS Total, BAS 
Subscales, AMS, SPQ, and eyes closed overall alpha (8-12 Hz) asymmetry scores. 
 
EC1      EC2            EC3 EC4 AMS SPQ BIS BAS 
         TOT RR D FS 
BAS FS            
 D 
 
RR 
         
 
 
 
.547** 
.529** 
 
.495** 
 
 
 
BIS 
TOT        
 
 
 
.397** 
.825** 
 
.256* 
.824** 
 
.333** 
.829** 
 
.391** 
SPQ        -.027 .058 .001 -.076 .199 
AMS       -.265* -.031 .219 .184 .249* .118 
EC4      .051 .180 .105 .127 .100 .174 .048 
EC3     .691** -.016 .080 .023 .008 .020 .063 -.056 
EC2    .728** .812** -.051 .141 .063 .108 .021 .169 .085 
EC1   .771** .640** .761** -.069 .243* .110 .112 .082 .122 .076 
Mean  .162 .171 .155 .156 13.21 7.74 19.30 38.62 14.38 12.09 12.14 
SD  .203 .203 .187 .181 3.255 4.637 1.705 3.759 1.532 1.406 1.614 
*p < .05; **p < .01 
Note. AMS = Appetitive Motivation Scale, SPQ = Sensitivity to Punishment Questionnaire, BIS 
= Behavioral Inhibition System, BAS TOT = Behavioral Activation System Total, BAS RR = 
Behavioral Activation System Reward Responsiveness, BAS D = Behavioral Activation System 
Drive, BAS FS = Behavioral Activation System Fun Seeking, EC1 = alpha asymmetry score for 
eyes closed 1 condition, EC2 = alpha asymmetry score for eyes closed 2 condition, EC3 = alpha 
asymmetry score for eyes closed 3 condition, EC4 = alpha asymmetry score for eyes closed 4 
condition.
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Table 7. Correlation matrix showing relationships between BIS Total, BAS Total, BAS 
Subscales, AMS, SPQ, and eyes open overall alpha (8-12 Hz) asymmetry scores. 
 
 EO1 EO2 EO3 EO4 AMS SPQ BIS  BAS  
       TOT RR             D FS 
BAS FS           
 D 
 
RR 
        
 
 
 
.547** 
.529** 
 
.495** 
 
 
 
BIS 
TOT        
 
 
 
.397** 
.825**      .824** 
 
.256*       .333** 
.829** 
 
.391** 
SPQ        -.027 .058 .001          -.076 .199 
AMS       -.265* -.031 .219 .184         .249* .118 
EO4      -.076 .189 -.075 -.040 -.019          .045 -.114 
EO3     .458** .001 .166 -.080 .009 .068          .028 -.070 
EO2    .394** .598** -.146 .218 .020 .080 .164       .063 -.024 
EO1   .317** .423** .494** .053 .203 -.016 -.016 -.115          .052 .027 
Mean  .140 .163 .106 .148 13.21 7.74 19.30 38.62 14.38        12.09 12.14 
SD  .280 .267 .234 .270 3.255 4.637 1.705 3.759 1.532        1.406 1.614 
*p < .05; **p < .01 
Note. AMS = Appetitive Motivation Scale, SPQ = Sensitivity to Punishment Questionnaire, BIS 
= Behavioral Inhibition System, BAS TOT = Behavioral Activation System Total, BAS RR = 
Behavioral Activation System Reward Responsiveness, BAS D = Behavioral Activation System 
Drive, BAS FS = Behavioral Activation System Fun Seeking, EO1 = alpha asymmetry score for 
eyes open 1 condition, EO2 = alpha asymmetry score for eyes open 2 condition, EO3 = alpha 
asymmetry score for eyes open 3 condition, EO4 = alpha asymmetry score for eyes open 4 
condition.
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Correlations between RST factors and ERP Amplitudes. In order to investigate the 
hypothesis BAS scores would be associated with larger P300 amplitudes during negative oddball 
stimuli presentations and higher BIS scores would be associated with larger P300 amplitudes 
during positive oddball stimuli presentations, correlation analyses were conducted between P300 
target amplitudes at P3, Pz, and P4 electrodes during each affective condition and all RST factors 
(e.g., BIS, BAS subscales, AMS, and SPQ). Results are presented in Tables 8-9. No significant 
correlations were observed between P300 amplitudes to either positive or negative targets and 
variables of interest.
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Table 8. Correlation matrix showing relationships between BIS Total, BAS Total, BAS 
Subscales, AMS, SPQ, and P300 amplitudes for positive targets. 
 
 PTP3 PTPz PTP4 AMS SPQ BIS BAS 
      TOT RR D FS 
BAS FS           
 D 
 
RR 
        
 
 
 
.547** 
.529** 
 
.495** 
 
 
 
BIS 
TOT       
 
 
 
.397** 
.825** 
 
.256* 
.824** 
 
.333** 
.829** 
 
.391** 
SPQ       -.027 .058 .001 -.076 .199 
AMS      -.265* -.031 .219 .184 .249* .118 
PTP4     -.048 .081 .024 -.014 -.061 .008 .018 
PTPz    .927** -.091 .074 .009 .004 -.037 -.011 .054 
PTP3   .011 .003 .061 .084 .051 .072 .044 .073 .063 
Mean  51.51 8.031 8.874 13.21 7.74 19.30 38.62 14.38 12.09 12.14 
SD  364.0 7.213 7.041 3.255 4.637 1.705 3.759 1.532 1.406 1.614 
*p < .05; **p < .01 
Note. AMS = Appetitive Motivation Scale, SPQ = Sensitivity to Punishment Questionnaire, BIS 
= Behavioral Inhibition System, BAS TOT = Behavioral Activation System Total, BAS RR = 
Behavioral Activation System Reward Responsiveness, BAS D = Behavioral Activation System 
Drive, BAS FS = Behavioral Activation System Fun Seeking, PTP3 = P300 response to positive 
target condition at electrode P3,PTPz = P300 response to positive target condition at electrode 
Pz, PTP4 = P300 response to positive target condition at electrode P4.
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Table 9. Correlation matrix showing relationships between BIS Total, BAS Total, BAS 
Subscales, AMS, SPQ, and P300 amplitudes for negative targets. 
 
 NTP3 NTPz NTP4 AMS SPQ BIS   BAS  
      TOT RR D FS 
BAS FS           
 D 
 
RR 
        
 
 
 
.547** 
.529** 
 
.495** 
 
 
 
BIS 
TOT       
 
 
 
.397** 
.825** 
 
.256* 
.824** 
 
.333** 
.829** 
 
.391** 
SPQ       -.027 .058 .001 -.076 .199 
AMS      -.265* -.031 .219 .184 .249* .118 
NTP4     -.112 -.029 -.082 -.063 -.202 .024 .023 
NTPz    .932** -.100 -.052 -.106 -.073 -.158 .001 -.021 
NTP3   .288* .209 .063 .081 .041 .069 .035 .076 .060 
Mean  20.721 8.693 9.791 13.21 7.74 19.30 38.62 14.38 12.09 12.14 
SD  107.69 8.360 7.666 3.255 4.637 1.705 3.759 1.532 1.406 1.614 
*p < .05; **p < .01 
Note. AMS = Appetitive Motivation Scale, SPQ = Sensitivity to Punishment Questionnaire, BIS 
= Behavioral Inhibition System, BAS TOT = Behavioral Activation System Total, BAS RR = 
Behavioral Activation System Reward Responsiveness, BAS D = Behavioral Activation System 
Drive, BAS FS = Behavioral Activation System Fun Seeking, NTP3 = P300 response to negative 
target condition at electrode P3,NTPz = P300 response to negative target condition at electrode 
Pz, NTP4 = P300 response to negative target condition at electrode P4.
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Correlations between Brief COPE subscales and EEG asymmetry. Correlation 
analyses were conducted in order to explore potential associations between Brief COPE 
subscales and frontal baseline asymmetry scores. As previously stated, the inverse of the 
calculated asymmetry score is believed to represent increased brain activity, thus negative scores 
reflect greater relative right hemisphere EEG activity, and positive scores reflect greater relative 
left activity (Davidson, 1988). Correlation analyses for self-reported Brief COPE subscales 
scores with the asymmetry scores are presented in Table 10. A significant correlation was 
observed between EC3 (M = .155 microvolts, SD = .187) and BC: Substance Use (M = 2.82, SD 
= 1.3837), r(73) = 0.241, p = 0.037, 95% CI [0.015, 0.443], indicating that higher self-reported 
tendency to engage in substance use as a coping strategy was associated with greater relative left 
frontal baseline activity. Another significant correlation was observed between EO3 (M = .106 
microvolts, SD = .234) and BC: Disengagement (M =3.20, SD = 3.559), r(73) = 0.243, p = 0.035, 
95% CI [0.017, 0.445], indicating higher self-reported tendency to use disengagement as a 
coping strategy was also associated with greater relative left frontal baseline activity. No other 
significant correlations were observed between alpha asymmetry scores and variables of interest.
72  
Table 10. Correlations between Brief COPE scores and eyes closed overall alpha (8-12 Hz) 
asymmetry scores. 
 
Brief COPE 
Subscales 
EC1 EC2 EC3 EC4 EO1 EO2 EO3 EO4  
Mean 
 
SD 
Active -.022 .052 -.072 -.080 -.055 .102 .094 .039 5.86 1.512 
Planning -.114 -.054 -.008 -.209 -.028 -.085 -.099 .013 6.12 1.442 
Positive Reframe .068 .135 .073 .093 .210 .139 .030 .180 6.38 3.749 
Acceptance .153 .147 .050 .153 -.004 .178 .103 .051 5.63 1.394 
Humor -.110 -.082 -.062 -.059 -.139 .024 -.167 .048 4.64 1.794 
Religion .027 -.014 -.208 -.060 .085 .066 -.066 .217 4.99 2.176 
Emotional 
Support 
.066 .097 .003 -.022 -.002 .048 .046 .072 5.37 2.006 
Instrumental 
Support 
.067 .079 -.058 -.036 .102 .050 .038 .119 5.38 1.918 
Self-distraction .183 .186 .170 .091 .041 .115 .119 .149 5.61 1.609 
Denial .031 .081 -.013 .132 .187 -.009 .074 .050 2.83 1.182 
Venting .079 .112 .051 .033 .082 -.008 .161 .207 3.82 1.116 
Substance Use .139 .188 .241* .208 .056 .012 .176 .099 2.82 1.383 
Disengagement -.097 .003 -.004 -.007 -.075 -.069 .243* -.031 3.20 3.559 
Self-blame .122 .166 .098 .165 .006 .071 .085 -.032 3.95 1.469 
Mean .162 .171 .155 .156 .140 .163 .106 .148  
SD .203 .203 .187 .181 .280 .267 .234 .270 
*p < .05; **p < .01 
Note. EC1 = alpha asymmetry score for eyes closed 1 condition, EC2 = alpha asymmetry score 
for eyes closed 2 condition, EC3 = alpha asymmetry score for eyes closed 3 condition, EC4 = 
alpha asymmetry score for eyes closed 4 condition. EO1 = alpha asymmetry score for eyes open 
1 condition, EO2 = alpha asymmetry score for eyes open 2 condition, EO3 = alpha asymmetry 
score for eyes open 3 condition, EO4 = alpha asymmetry score for eyes open 4 condition.
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Correlations between Brief COPE subscales and ERP Amplitudes. Correlation 
analyses were conducted between Brief COPE scores and P300 responses to positive and 
negative target stimuli in order to these explore potential associations. Results are presented in 
Table 15. A significant correlation was observed between Disengagement (M =3.20, SD = 3.559) 
and P300 amplitudes in response to positive target stimuli presentations at two electrode sites: 
PTPz (M = 8.031 microvolts, SD = 7.213), r(70) = -0.285, p = 0.015, 95% CI [-0.49, -0.050], and 
PTP4 (M = 8.874 microvolts, SD = 7.041), r(70) = -0.249, p = 0.035, 95% CI [-0.46, -0.012]. As 
higher P300 amplitudes are thought to indicate a response to novel stimuli, these findings 
suggest that people who reported having a lower tendency to use disengagement as a coping 
strategy may be more sensitive to perceiving positively valenced stimuli infrequently presented 
among negative visual stimuli. No other significant correlations were observed between P300 
amplitudes to either positive or negative targets and variables of interest.
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Table 11. Correlations between Brief COPE scores and P300 amplitudes for positive and 
negative targets. 
Brief COPE 
Subscales 
PTP3 PTPz PTP4 NTP3 NTPz NTP4  
Mean 
 
SD 
Active -.015 -.052 -.066 -.015 .005 .032 5.86 1.512 
Planning .019 .063 .040 .009 -.116 -.121 6.12 1.442 
Positive Reframe -.056 -.003 .038 -.053 -.021 .004 6.38 3.749 
Acceptance -.070 -.111 -.150 -.068 -.047 -.083 5.63 1.394 
Humor -.037 .098 .112 -.032 .059 .000 4.64 1.794 
Religion .060 .127 .111 .060 .119 .027 4.99 2.176 
Emotional 
Support 
-.076 .155 .157 -.076 -.028 -.016 5.37 2.006 
Instrumental 
Support 
-.082 -.101 -.044 -.083 -.045 -.060 5.38 1.918 
Self-distraction -.045 .165 .133 -.048 -.025 -.094 5.61 1.609 
Denial .019 -.089 -.127 .014 -.080 -.038 2.83 1.182 
Venting .019 -.059 -.039 .019 -.090 -.060 3.82 1.116 
Substance Use -.071 .006 -.028 -.059 .077 .044 2.82 1.383 
Disengagement -.046 -.285* -.249* -.049 -.174 -.168 3.20 3.559 
Self-blame -.078 -.081 -.095 -.077 -.033 -.010 3.95 1.469 
Mean 51.51 8.031 8.874 20.721 8.693 9.791  
SD 364.0 7.213 7.041 107.69 8.360 7.666 
*p < .05; **p < .01 
Note. PTP3 = P300 response to positive target condition at electrode P3,PTPz = P300 response 
to positive target condition at electrode Pz, PTP4 = P300 response to positive target condition at 
electrode P4. NTP3 = P300 response to negative target condition at electrode P3,NTPz = P300 
response to negative target condition at electrode Pz, NTP4 = P300 response to negative target 
condition at electrode P4.
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Summary of Findings 
 
In summary, partial support for the major hypotheses was observed. The hypothesis that 
BIS would be positively associated with behavioral intentions to adhere to the disadvantage- 
framed treatment recommendations was supported. BIS was a significant positive predictor of 
behavioral intentions to adhere to the disadvantage-framed message. The hypothesis that BAS 
subscales would be positively associated with behavioral intentions to adhere to either health 
message was not supported. 
It was hypothesized that higher BAS scores would be associated with larger P300 
amplitudes during negative oddball stimuli presentations. It was also hypothesized that higher 
BIS scores would be associated with larger P300 amplitudes during positive oddball stimuli 
presentations. Furthermore, oddball P300 amplitudes were expected to significantly contribute to 
prediction of behavioral intentions across both health messages. Unfortunately, none of the 
oddball P300 amplitudes significantly contributed to either of the multiple regression models, 
nor were they found to be significantly associated with facets of RST. Exploratory correlation 
analyses indicated that BC: Disengagement was significantly, negatively correlated with PTPz 
and PTP4, suggesting that people who reported having a lower tendency to use disengagement as 
a coping strategy may be more sensitive to perceiving positively valenced stimuli infrequently 
presented among negative visual stimuli. In summary, no evidence was found during the current 
study to support hypotheses associating P300 amplitudes to RST factors or behavioral intentions. 
It was hypothesized that higher BAS scores would be associated with greater relative left 
frontal asymmetry while higher BIS scores would be associated with greater relative right frontal 
asymmetry. Only one significant correlation was observed between baseline asymmetry values 
and any facet of RST. A significant, positive correlation was found between EC1 and SPQ,
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indicating that higher SPQ trait values were associated with greater relative left frontal baseline 
activity. As SPQ is thought to be related to BIS trait, this finding does not support the hypothesis 
that BIS-related traits would be associated with greater relative right frontal baseline activity as 
has been observed in previous research. 
Finally, it was predicted that greater relative left frontal asymmetry would be associated 
with greater behavioral intentions to adhere to the advantage-framed message, while greater 
relative right frontal asymmetry would be associated with higher behavioral intentions to adhere 
to the disadvantage-framed message. In partial support of this hypothesis is the observation that 
EC3 was a significant, negatively weighted predictor variable within the full multiple regression 
model predicting behavioral intentions to the disadvantage-framed message. This finding 
demonstrates partial support for this hypothesis, indicating that participants with lower relative 
left hemisphere baseline cortical activity endorsed higher behavioral intentions to adhere to the 
disadvantage-framed message. 
Other notable findings from Study One included the non-significant difference observed 
in behavioral intentions across the message conditions prior to considering individual differences 
in traits and coping strategies. This is important to note simply because it highlights the 
importance of carefully considering individual differences in traits prior to tailoring a health 
message to a specific patient. In other words, neither health message condition elicited a higher 
level of behavioral intentions over the other, but specific traits, coping strategies, and an EEG 
biomarker were found to significantly predict behavioral intentions to adhere to different health 
messages. 
Another important finding was the observation that elicitation of affect during the 
advantage-framed health message significantly contributed to both multiple regression models,
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with valence significantly and positively contributing to the advantage-framed message condition 
and control significantly and positively contributing to the disadvantage-framed message 
condition. These findings indicate that those who reported higher levels of positive affect in 
response to the advantage-framed message were more likely to endorse higher levels of 
behavioral intentions after viewing it. Those who endorsed higher feelings of control after 
viewing the disadvantage-framed message were more likely to endorse higher levels of 
behavioral intentions to adhere to it. Furthermore, humor as a coping strategy significantly, 
negatively contributed to both models, as well, indicating that those who endorsed using higher 
levels of humor as a coping strategy were more likely to endorse lower levels of behavioral 
intentions to both health messages. 
A facet of RST, BAS Fun Seeking, was found to be significantly, negatively correlated 
with arousal ratings after viewing the advantage-framed message. Many of the coping strategies 
were also significantly associated with affect ratings to the health messages. Acceptance was 
positively related to control ratings after viewing the advantage-framed message. Self-blame was 
positively related to both arousal and control ratings after viewing the disadvantage-framed 
message. Religion was negatively associated with valence ratings after the disadvantage-framed 
message, and substance use was negatively associated with control ratings after the 
disadvantage-framed message. Substance use was also significantly, positive correlated with 
EC3, indicating that higher ratings on this coping strategy are associated with greater relative left 
hemisphere baseline activity. Similarly, a significant, positive correlation was found between 
EO3 and disengagement, indicating higher ratings on this coping strategy are also associated 
with greater relative left hemisphere baseline activity.
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Although a major strength of this laboratory study was that many variables could be 
controlled, this unfortunately also poses a threat to generalizability. This sample consisted of 
young adults who had not actually received a chronic health diagnosis and who could only 
indicate their behavioral intentions to adhere to simulated treatment recommendations. 
Additionally, an exclusionary criterion was that participants could not have ever received any 
other chronic health diagnosis, which is not consistent with the experiences of many patients 
who suffer from obstructive sleep apnea who have often received multiple chronic health 
diagnoses and are concurrently managing many treatment regimens in addition to CPAP. The 
second study will attempt to address many of these factors that threaten generalizability of 
findings from Study One.
  
 
CHAPTER VI: STUDY TWO 
 
Method 
 
Participants. Data were collected from 76 adults recruited from the Vidant Sleep Center 
in Greenville, NC. This sample of participants is part of an ongoing larger investigation of CPAP 
nonadherence, chosen based on the availability of longitudinal adherence data needed to 
complete proposed statistical analyses. Participants were patients who were referred for a 
diagnostic or follow-up polysomnogram overnight study who subsequently received a diagnosis 
of obstructive sleep apnea and were prescribed a device to wear each night while sleeping. All 
participants gave informed consent to the protocol, which was approved by the East Carolina 
University and Medical Center Institutional Review Board (Appendix C & K). 
Procedure. Participants were asked to participate in the study prior to admission into the 
room in which they would be monitored during their polysomnogram. After consent was 
obtained, participants completed several self-report inventories including the BIS/BAS, SPQ, 
and AMS. This process took approximately 30 minutes. Additional demographic information 
and a subjective severity rating (i.e., one question asking patients to rate the severity of their 
sleep problem on a scale from 1= mildly upsetting to 5= totally incapacitating) was collected 
from medical records in accordance with consent documents. 
Frontal asymmetry data were collected during eyes open and eyes closed segments of 
each patient’s diagnostic polysomnogram study while lying down in the bed provided at the 
Vidant Sleep Center. Polysomnogram studies were performed and scored in accordance with 
standard guidelines and conducted by certified sleep technicians (Iber, Ancoli-Israel, Chesson, & 
Quan, 2007). All recordings were converted to European Data Format. Electrodes were arranged
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according to the 10-20 international system (Jasper, 1958). EEG data were recorded from 32 
active electrode sites using linked ears (A1 and A2) as a reference (monopolar montage). 
Electrode placement included Frontal: F3, Fz, F4; Central: Cz, C3, C4; Temporal: T3, T4; 
Parietal: Pz, P3, P4; and Occipital: O1, O2. In addition, electrodes were placed on the outer 
cantus of each eye so that eye movement recordings could be obtained. Excessive artifact 
associated with body and eye movement was excluded during off-line processing and prior to 
averaging. Artifact reduction was completed prior to computing averages for EEG data. Data 
were stored and analyzed on a PC Pentium Computer. The EEG data were converted on line for 
display, storage, and analysis (Everhart & Demaree, 2003). 
Adherence data were obtained from an online database provided by each patient’s 
 
healthcare company. Treatment adherence was defined as wearing the OSA treatment apparatus 
 
>4 hours per night on 70% of the nights, as these criteria support significant improvement in 
reduction of OSA symptoms (Kryger et al., 2000). Adherence data were collected for analysis at 
the following time-points after receiving their treatment apparatus: 1) 7 days, 2) 30 days, 3) 60 
days, and 4) 90 days (see Figure 5 for summary of procedures). 
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Figure 5. Summary of Study Two procedures. 
 
Apparatuses. Participants included in the present study were prescribed one of the 
following previously described apparatuses to treat their OSA symptoms: CPAP (continuous
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positive airway pressure), BiPAP (Bilevel Positive Airway Pressure), or APAP (Automatic 
Positive Airway Pressure). CPAP utilizes continuous and direct air pressure to keep the airway 
unobstructed, delivered from the air compressor-like CPAP machine through a mask placed over 
the nose and/or mouth. BiPAP provides two levels of pressure and three different modes within 
the patient’s control of adjustment. APAP continuously monitors the patient’s breathing using 
pressure sensors, and adjusts the pressure to accommodate the patient’s breathing (e.g., increases 
the pressure when the patient is unable to breathe) (Moran, Highsmith, Lehockey, & Everhart, 
2012). Although biomedical factors such as apparatus adjustments are important to consider 
when a patient is demonstrating nonadherence behaviors, three recent meta-analyses 
investigating adherence across different pressure-adjusting treatment modalities indicated 
generally no evidence for increased adherence, except for a significant 11-13 min/night increase 
for APAP, which is only prescribed to selected patients (Bakker & Marshall, 2012; Ip et al., 
2012; Smith & Lasserson, 2009). Thus, comparisons across different apparatus modalities were 
not included in the present study. Additionally, as the majority of patients were prescribed CPAP 
in this sample, outcomes are reported in terms of CPAP adherence, but also include those few 
patients in this sample that used a different apparatus. 
Statistical analyses. Primary analyses performed were logistic regressions predicting 
nonadherence as defined by Kryger and colleagues (2000) from responses to the BIS/BAS 
scales, AMS, and SPQ, as well as from baseline asymmetry values obtained from 
polysomnogram. Logistic regression was chosen as the primary analysis in order to remain 
consistent with the current criteria for adherence offered by insurance providers. Multiple 
regression analyses were also employed in order to more fully investigate the continuous nature 
of adherence as opposed to employing the strict adherence cut-off criteria, in hopes of better
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informing motivational health behavior interventions. Correlation analyses for BIS and BAS 
scores with EEG asymmetry scores were also conducted to investigate these relationships within 
this clinical sample. Alpha level was set at .05 in tests of statistical significance. Data analyses 
were performed using SPSS version 17.0. 
Results 
 
Descriptive statistics. The current sample consisted of 42 men and 34 women. 
Demographic characteristics of this sample consisted of individuals self-identifying as Caucasian 
(49), African American (25), and Bi-racial (1), with one participant declining to answer this 
demographic item. The mean age of participants was 55.7 years, with a range from 27 to 93 
years of age. The average body mass index (BMI) of the current sample was 47.71, indicative of 
 
Class III Obesity. BMI range consisted of individuals from the normal BMI classification at 
 
21.70 to very severely obese at 69.41. There were no significant differences in adherence 
between men and women at any time-point: 7 days, t(58) = .957, p = .342; 30 days, t(68) = 
1.434, p = .156; 60 days, t(41) = .996, p = .325; 90 days, t(45) = 1.360, p = .181. There were also 
no significant differences in adherence between Caucasians and African Americans at any time- 
point: 7 days, t(56) = -.437, p = .664; 30 days, t(67) = -1.227, p = .224; 60 days, t(39) = -1.430, p 
= .161; 90 days, t(43) = -1.957, p = .057. 
 
Descriptive statistics of the self-report inventories and baseline asymmetry values are 
provided in Table 12.
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Table 12. Descriptive statistics for variables of interest from self-report inventories and baseline 
asymmetry values. 
 
Predictor Variable Mean SD 
BIS 18.99 4.59 
BAS Drive 10.08 3.14 
BAS Reward Responsiveness 16.21 4.33 
BAS Fun Seeking 10.11 2.98 
Appetitive Motivation Scale 10.08 4.01 
Sensitivity to Punishment Questionnaire 8.89 5.90 
Eyes Open Baseline Asymmetry 0.066 0.25 
Eyes Closed Baseline Asymmetry 0.010 0.29 
 
Due to variability in availability of adherence data at each time-point, analyses across 
 
each subset consist of different sample sizes. Of the 60 participants with adherence data available 
at the 7 day time-point, 38 participants (63.3%) met overall criteria for adherence. Out of 70 
participants, 42 (60.0%) were adherent at the 30 day time-point, while 25 out of 44 participants 
(56.8%) were adherent at the 60 day time-point. Out of the 47 participants with adherence data 
available at the 90 day time-point, 22 participants (46.8%) met adherence criteria (Figure 6). Of 
the 34 participants who have adherence data available at all time-points, 19 (55.9%) were 
adherent at 7 days, 17 (50%) were adherent at 30 days, 18 (52.9%) were adherent at 60 days, and 
14 (41.2%) were adherent at 90 days (Figure 7).
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Figure 6. Adherence and nonadherence percentages of all available data at each time-point. 
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Figure 7. Adherence and nonadherence percentages of participants with available adherence data 
at each time-point.
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Logistic regression analyses. Logistic regression analyses were employed to predict the 
probability that a participant would be nonadherent at each time-point. Prior to logistic 
regression analyses, Pearson correlations between predictor variables and adherence as a 
dichotomous variable were investigated. Predictor variables consisted of BIS, BAS subscales 
including BAS Drive, BAS Fun Seeking, and BAS Reward Responsiveness, AMS, SPQ, and 
baseline asymmetry values during eyes open and eyes closed sessions of the overnight 
polysomnogram. Demographic and health variables were also investigated for inclusion in the 
models, including age, sex, race (1 = African American, 2 = Caucasian), Body Mass Index 
(BMI), Subjective Severity Rating, and apnea-hypopnea index (AHI). 
Only those predictors that were significant at the .10 level were retained in subsequent 
models. Among those variables dropped prior to all logistic regression analyses across all time- 
points were the following: BAS Drive, BAS Reward Responsiveness, BAS Fun Seeking, Eyes 
Open Baseline Asymmetry, Eyes Closed Baseline Asymmetry, sex, race, BMI, and AHI. 
Correlation coefficients for adherence (0= adherent, 1= nonadherent) at each time-point and 
predictor variables are displayed in Table 13.
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Table 13. Pearson correlations for nonadherence at each time-point and predictor variables. 
 Nonadherence (No or Yes) 
Predictor Variable 7 Days 30 Days 60 Days 90 Days 
Sample Size 60 70 44 47 
BIS 0.224* 0.190 0.125 0.009 
BAS Drive -0.121 -0.073 -0.188 -0.155 
BAS Reward Responsiveness 0.140 0.090 0.189 -0.055 
BAS Fun Seeking -0.069 0.048 0.037 0.037 
Appetitive Motivation Scale 0.247* 0.143 0.196 0.146 
Sensitivity to Punishment Questionnaire 0.236* 0.138 0.122 -0.043 
Eyes Open Baseline Asymmetry 0.011 -0.080 -0.026 -0.112 
Eyes Closed Baseline Asymmetry 0.049 -0.049 -0.093 -0.064 
Age -0.202 -0.239** -0.378** -0.270* 
Sex 0.076 0.094 0.177 0.157 
Race -0.191 -0.063 -0.135 -0.232 
BMI 0.180 0.172 0.110 0.237 
Subjective Severity Rating 0.097 0.113 0.303* 0.396*** 
AHI 0.180 0.150 0.128 0.045 
*** Correlation is significant at the 0.01 level (2-tailed) 
**Correlation is significant at the 0.05 level (2-tailed) 
*p value of correlation is at the 0.10 level (2-tailed)
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Separate logistic regression analyses were employed to predict that a participant would be 
nonadherent at each time-point. A standard 0.5 cutoff for classification was used for all logistic 
regression analyses. Table 14 displays sensitivity, specificity, positive predictive value, and 
negative predictive value for each full logistic regression model for each time-point. Table 15 
shows the logistic regression coefficient, Wald test, and odds ratio for each of the predictors 
included in each model for their respective time-points. 
Seven days logistic regression model. Three correlations were observed between 
nonadherence behavior at seven days and predictor variables that did not reach statistical 
significance, but achieved a p < .10, and were thus included in the logistic regression analysis. 
These included three positive correlations between nonadherence at seven days and BIS (M = 
18.986, SD = 4.587), r(55) = 0.224, p = 0.100, 95% CI [-0.043, 0.461], AMS (M = 10.083, SD = 
 
4.006), r(56) = 0.247, p = 0.067, 95% CI [-0.017, 0.478], and SPQ (M = 8.889, SD =5.904), 
r(56) = 0.236, p = 0.080, 95% CI [-0.028, 0.496], indicating that higher self-reported scores on 
these questionnaires were associated with higher rates of nonadherence behavior at seven days. 
A test of the full logistic model for nonadherence at the seven day time-point included 
BIS, AMS, and SPQ as predictor variables. The logistic regression model was not statistically 
significant, χ2 (3) = 7.673, p = 0.053. The model explained 18.2% (Nagelkerke R2) of the 
variance in nonadherence and correctly classified 70.4% of cases. The model was able to 
correctly classify 88.6% of those who were adherent and 36.8% of those who were not adherent. 
Employing a 0.05 criterion of statistical significance, none of the three predictor variables had a 
significant partial effect: BIS (p = 0.094), AMS (p = 0.051), and SPQ (p = 0.555). 
Thirty days logistic regression model. A test of the full logistic model for nonadherence 
at the thirty day time-point included age as a predictor variable, as age (M = 55.711, SD =
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11.747) was significantly, negatively correlated with nonadherence at 30 days (M = 1.40, SD = 
0.493), r(70) = -0.239, p = 0.046, 95% CI [-0.448, -0.005], indicating that higher age was 
significantly associated with lower rates of nonadherence at 30 days. The logistic regression 
model was statistically significant, χ2 (1) = 4.172, p = 0.041. The model explained 7.8% 
(Nagelkerke R
2
) of the variance in nonadherence and correctly classified 57.1% of cases. The 
 
model was able to correctly classify 78.6% of those who were adherent and 25.0% of those who 
were not adherent. Employing a 0.05 criterion of statistical significance, age as a predictor 
variable did not have a significant partial effect: age (p = 0.052), although the Wald χ2 
test is conservative and thus this finding may indicate the need for further investigation in future 
 
research. 
 
Sixty days logistic regression model. A test of the full logistic model for nonadherence at 
the sixty day time-point included age and subjective severity rating as predictor variables. Age 
(M = 55.711, SD = 11.747) was significantly, negatively associated with nonadherence at 60 
days (M = 1.43, SD = 0.501), r(44) = -0.378, p = 0.011, 95% CI [-0.606, -0.092], indicating that 
higher age was significantly associated with lower rates of nonadherence at 60 days. Subjective 
severity rating (M = 2.420, SD = 1.063) was positively associated with nonadherence at 60 day 
(M = 1.43, SD = 0.501), r(39) = 0.303, p = 0.061, 95% CI [-0.013, 0.564], indicating that higher 
subjective severity ratings were associated with higher rates of nonadherence at 60 days. The 
logistic regression model was statistically significant, χ
2 
(2) = 9.461, p = 0.009. The model 
 
explained 28.9% (Nagelkerke R
2
) of the variance in nonadherence and correctly classified 66.7% 
of cases. The model was able to correctly classify 77.3% of those who were adherent and 52.9% 
of those who were not adherent. Employing a 0.05 criterion of statistical significance, age had a 
significant partial effect while subjective severity rating did not: age (p = 0.034), subjective
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severity rating (p = 0.058). A one-unit decrease in age is associated with the odds of being 
nonadherent increasing by a multiplicative factor of 1.094. In other words, for each one year 
reduction in age, the risk of nonadherence in this sample increased by a factor of 1.094. This is 
equivalent to a risk of nonadherence increasing by a factor of 1.094 for every five year decrease 
in age. 
Ninety days logistic regression model. A test of the full logistic model for nonadherence 
at the ninety day time-point included age and subjective severity rating as predictor variables. 
Subjective severity rating (M = 2.420, SD = 1.063) was significantly, positively associated with 
nonadherence at 90 days (M = 1.53, SD = 0.504), r(43) = 0.396, p = 0.009, 95% CI [0.109, 
0.622], indicating that higher subjective severity ratings were significantly associated with higher 
rates of nonadherence at 90 days. A nonsignificant negative correlation was observed between 
age (M = 55.711, SD = 11.747) and nonadherence at 90 days (M = 1.53, SD = 0.504), r(47) = - 
 
0.270, p = 0.066, 95% CI [-0.517, 0.018], indicating that higher age was associated with lower 
rates of nonadherence at 90 days. The logistic regression model was statistically significant, χ2 
(2) = 12.288, p = 0.002. The model explained 33.1% (Nagelkerke R
2
) of the variance in 
nonadherence and correctly classified 65.1% of cases. The model was able to correctly classify 
66.7% of those who were adherent and 63.6% of those who were not adherent. Employing a 0.05 
criterion of statistical significance, age and subjective severity rating as predictor variables had 
partial significant effects: age (p = 0.049), subjective severity rating (p = 0.011). At the ninety 
days time-point, a one-unit decrease in age is associated with the odds of being nonadherent 
increasing by a multiplicative factor of 1.081. In other words, for each one year reduction in age, 
the risk of nonadherence in this sample increased by a factor of 1.081. A one-unit increase in
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subjective severity rating of obstructive sleep apnea at the time of diagnosis is associated with 
the odds of being nonadherent by a multiplicative factor of 3.272.
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Table 14. Sensitivity, specificity, positive predictive value, and negative predictive value for full 
models at each time-point. 
 Full Model for Each Time-Point 
 7 Days 
(BIS, SPQ, 
AMS) 
30 Days 
(Age) 
60 Days 
(Age, Severity 
Rating) 
90 Days 
(Age, Severity 
Rating) 
Sample Size 60 70 44 47 
Sensitivity (Nonadherence) 36.8% 25.0% 52.9% 63.6% 
Specificity (Adherence) 88.6% 78.6% 77.3% 66.7% 
Positive Predictive Value 63.6% 43.8% 64.3% 66.7% 
Negative Predictive Value 72.1% 61.1% 68.0% 63.6% 
 
Table 15. Logistic regression predicting nonadherence. 
 Nonadherence (No or Yes) 
Predictor Variable 7 Days 30 Days 60 Days 90 Days 
Sample Size 60 70 44 47 
BIS 
B 
Wald χ2 
p 
Odds Ratio 
 
0.133 
2.806 
0.094 
1.142 
 
--- 
--- 
--- 
--- 
 
--- 
--- 
--- 
--- 
 
--- 
--- 
--- 
--- 
Appetitive Motivation Scale 
B 
Wald χ2 
p 
Odds Ratio 
 
0.171 
3.823 
0.051 
1.186 
 
--- 
--- 
--- 
--- 
 
--- 
--- 
--- 
--- 
 
--- 
--- 
--- 
--- 
Sensitivity to Punishment Questionnaire 
B 
Wald χ2 
p 
Odds Ratio 
 
0.035 
0.349 
0.555 
1.036 
 
--- 
--- 
--- 
--- 
 
--- 
--- 
--- 
--- 
 
--- 
--- 
--- 
--- 
Subjective Severity Rating 
B 
Wald χ2 
p 
Odds Ratio 
 
--- 
--- 
--- 
--- 
 
--- 
--- 
--- 
--- 
 
0.868 
3.601 
0.058 
2.383 
 
1.185 
6.494 
0.011 
3.272 
Age 
B 
Wald χ2 
p 
Odds Ratio 
 
--- 
--- 
--- 
--- 
 
-0.044 
3.776 
0.052 
0.957 
 
-0.089 
4.517 
0.034 
0.914 
 
-0.078 
3.877 
0.049 
0.925 
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Multiple regression analyses. Multiple regression analyses were employed to further 
investigate the utility of the predictor variables for informing health behavior interventions 
across each time-point. Prior to conducting separate multiple regression analyses, Pearson 
correlations between predictor variables and total hours of CPAP use at each time-point were 
investigated. Predictor variables consisted of the Behavioral Activation subscales (BAS) 
including BAS Drive, BAS Fun Seeking, and BAS Reward Responsiveness, the Behavioral 
Inhibition Scale (BIS), the Appetitive Motivation Scale (AMS), the Sensitivity to Punishment 
Questionnaire (SPQ), and baseline asymmetry values during eyes open and eyes closed sessions 
of the overnight polysomnogram. Demographic and health variables were also investigated for 
inclusion in the models, including age, sex, race, BMI, subjective severity rating, and apnea- 
hypopnea index (AHI). 
Only those predictors that had  zero-order correlations  significant at the .10 level were 
retained in subsequent models. Among those variables dropped from all multiple regression 
analyses across all time-points were the following: BAS Drive, BAS Fun Seeking, Appetitive 
Motivation Scale, Sensitivity to Punishment Questionnaire, Eyes Open Baseline Asymmetry, 
Eyes Closed Baseline Asymmetry, and sex. Correlation coefficients for total hours of CPAP use 
at each time-point and predictor variables are displayed in Table 16.
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Table 16. Pearson correlations for total hours of CPAP use at each time-point and predictor 
variables. 
 Total Hours of CPAP Use 
Predictor Variable 7 Days 30 Days 60 Days 90 Days 
Sample Size 60 70 44 47 
BIS -0.176 -0.229* 0.006 -0.039 
BAS Drive 0.069 0.042 0.011 0.040 
BAS Reward Responsiveness -0.232* -0.186 -0.322** -0.190 
BAS Fun Seeking 0.051 0.038 0.026 0.025 
Appetitive Motivation Scale -0.208 -0.117 -0.201 -0.117 
Sensitivity to Punishment Questionnaire -0.084 -0.138 -0.093 -0.087 
Eyes Open Baseline Asymmetry 0.090 -0.009 0.079 0.220 
Eyes Closed Baseline Asymmetry 0.084 0.008 0.268 0.148 
Age 0.231* 0.209* 0.337** 0.304** 
Sex -0.125 -0.171 -0.154 -0.199 
Race 0.101 0.148 0.275* 0.340** 
BMI -0.193 -0.184 -0.125 -0.227 
Subjective Severity Rating -0.248* -0.196 -0.135 -0.234 
AHI -0.212 -0.172 -0.077 -0.025 
*** Correlation is significant at the 0.01 level (2-tailed) 
**Correlation is significant at the 0.05 level (2-tailed) 
*p value of correlation is at the 0.10 level (2-tailed)
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Seven days multiple regression model. A test of the full multiple regression model for 
total hours of CPAP use at the seven day time-point included BAS Reward Responsiveness, age, 
and subjective severity rating as predictor variables. Three correlations were observed between 
total hours of CPAP use at seven days and predictor variables that did not reach statistical 
significance, but achieved a p < .10, and were thus included in the multiple regression analysis. 
These included negative correlations between total hours of CPAP use at seven days (M = 
36.639, SD = 20.302) and BAS Reward Responsiveness (M = 16.206, SD = 4.327), r(57) = - 
 
0.232, p = 0.083, 95% CI [0.019, 0.444], and subjective severity rating (M = 2.420, SD = 1.063), 
r(54) = -0.248, p = 0.070, 95% CI [-0.483, 0.021], indicating that higher scores on these self- 
report scales were associated with fewer total hours of CPAP use at seven days. There was a 
positive correlation between total hours of CPAP use at seven days (M = 36.639, SD = 20.302) 
and age (M = 55.711, SD = 11.747), r(60) = 0.231, p = 0.076, 95% CI [-0.024, 0.458], indicating 
that increased age was associated with more total hours of CPAP use at seven days. The 
assumptions of linearity, independence of errors, homoscedasticity, unusual points, and 
normality of residuals were met. These variables did not statistically significantly predict total 
hours of CPAP use at the seven day time-point, F(3, 47) = 2.492, p = 0.072, R
2 
= 0.137, 95% CI 
[0.000, 0.304]. None of the three variables added statistically significantly to the prediction, p > 
0.05. Regression coefficients and standard errors are displayed in Table 17.
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Table 17. Summary of multiple regression analysis at seven day time-point. 
 
 
Model Summary 
 
 
Model 
 
 
R 
 
 
R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
 
1 .370
a
 .137 .082 17.81538 
a. Predictors: (Constant), BASRR, Age, SeverityRating 
b. Dependent Variable: Total Hours in 1 week 
 
 
 
ANOVA 
 
 
 
Model 
Sum of 
Squares 
 
 
df 
 
 
Mean Square 
 
 
F 
 
 
Sig. 
1          Regression 
 
Residual 
 
Total 
2372.651 3 790.884 2.492 .072
a
 
14917.233 47 317.388   
17289.884 50    
a. Predictors: (Constant), BASRR, Age, Severity Rating 
b. Dependent Variable: Total Hours in 1 week 
 
 
 
Coefficients 
 
 
 
 
 
 
Model 
 
Unstandardized 
Coefficients 
 
Standardized 
Coefficients 
 
 
 
 
 
t 
 
 
 
 
 
Sig. 
95% 
Confidence 
Interval for B 
 
 
 
Correlations 
 
 
B 
Std. 
Error 
 
Beta 
Lower 
Bound 
Upper 
Bound 
Zero- 
order 
 
Partial 
 
Part 
1 (Constant) 
 
Severity 
Rating 
Age 
 
BASRR 
33.551 15.829  2.120 .039 1.707 65.394    
-2.688 2.511 -.146 -1.070 .290 -7.741 2.364 -.172 -.154 -.145 
.461 .233 .270 1.978 .054 -.008 .929 .248 .277 .268 
-.927 .581 -.219 -1.596 .117 -2.095 .242 -.207 -.227 -.216 
a. Dependent Variable: Total Hours in 1 week
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Thirty days multiple regression model. A test of the full multiple regression model for 
total hours of CPAP use at the thirty day time-point included BIS and age as predictor variables. 
Two correlations were observed between total hours of CPAP use at thirty days and predictor 
variables that did not reach statistical significance, but achieved a p < .10, and were thus 
included in the multiple regression analysis. A negative correlation was observed between total 
hours of CPAP use at thirty days (M = 151.660, SD = 79.673) and BIS (M = 18.986, SD = 
4.587), r(65) = -0.229, p = 0.067, 95% CI [-0.447, 0.015], indicating that higher levels of BIS 
were associated with fewer total hours of CPAP use at thirty days. A positive correlation was 
observed between total hours of CPAP use at thirty days (M = 151.660, SD = 79.673) and age (M 
= 55.711, SD = 11.747), r(70) = 0.209, p = 0.082, 95% CI [-0.027, 0.423], indicating that 
increased age was associated with more total hours of CPAP use at thirty days. The assumptions 
of linearity, independence of errors, homoscedasticity, unusual points, and normality of residuals 
were met. These variables did not statistically significantly predict total hours of CPAP use at the 
thirty day time-point, F(2, 62) = 2.593, p = 0.083, R
2 
= 0.077, 95% CI [0.000, 0.220]. Neither 
variable added statistically significantly to the prediction, p > 0.05. Regression coefficients and 
standard errors are displayed in Table 18.
97  
Table 18. Summary of multiple regression analysis at thirty day time-point. 
 
 
Model Summary 
 
 
Model 
 
 
R 
 
 
R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
 
1 .278
a
 .077 .047 74.94635 
a. Predictors: (Constant), BIS, Age 
b. Dependent Variable: Total Hours in 1 month 
 
 
ANOVA 
 
 
 
Model 
Sum of 
Squares 
 
 
df 
 
 
Mean Square 
 
 
F 
 
 
Sig. 
1          Regression 
 
Residual 
 
Total 
29125.752 2 14562.876 2.593 .083
a
 
348251.245 62 5616.956   
377376.997 64    
a. Predictors: (Constant), BIS, Age 
b. Dependent Variable: Total Hours in 1 month 
 
 
Coefficients 
 
 
 
 
 
 
Model 
 
Unstandardized 
Coefficients 
 
Standardized 
Coefficients 
 
 
 
 
 
t 
 
 
 
 
 
Sig. 
95.0% 
Confidence 
Interval for B 
 
 
 
Correlations 
 
 
B 
Std. 
Error 
 
Beta 
Lower 
Bound 
Upper 
Bound 
Zero- 
order 
 
Partial 
 
Part 
1 (Constant) 
Age 
BIS 
153.254 65.643  2.335 .023 22.036 284.472    
1.093 .844 .160 1.294 .201 -.595 2.781 .193 .162 .158 
-3.349 2.047 -.202 -1.636 .107 -7.441 .742 -.229 -.203 -.200 
a. Dependent Variable: Total Hours in 1 month
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Sixty days multiple regression model. A test of the full multiple regression model for 
total hours of CPAP use at the 60 day time-point included BAS Reward Responsiveness, age, 
and race as predictor variables. Two significant correlations were observed between total hours 
of CPAP use at 60 days and predictor variables, along with one correlation that did not reach 
significance but was included in the multiple regression analysis. A significant, negative 
correlation was observed between BAS Reward Responsiveness (M = 16.206, SD = 4.327) and 
total hours of CPAP use at 60 days (M = 300.797, SD = 150.908), r(41) = -0.322, p = 0.040, 95% 
CI [-0.572, -0.016], indicating that higher levels of BAS Reward Responsiveness was 
significantly associated with fewer total hours of CPAP use at 60 days. A significant positive 
correlation was observed between age (M = 55.711, SD = 11.747) and total hours of CPAP use at 
60 days (M = 300.797, SD = 150.908), r(43) = 0.337, p = 0.027, 95% CI [0.041, 0.578], 
indicating that increased age was associated with more total hours of CPAP use at 60 days. A 
nonsignificant, positive correlation was observed between total hours of CPAP use at 60 days (M 
= 300.797, SD = 150.908) and race (M = 1.680, SD = 0.498), r(42) = 0.275, p = 0.078, 95% CI [- 
 
0.031, 0.534], indicating that self-identifying as Caucasian was associated with more total hours 
of CPAP use at 60 days. The assumptions of linearity, independence of errors, homoscedasticity, 
unusual points, and normality of residuals were met. These variables statistically significantly 
predicted total hours of CPAP use at the sixty day time-point, F(3, 36) = 6.671, p = 0.001, R
2 
= 
0.357, 95% CI [0.080, 0.556]. All three variables added statistically significantly to the 
 
prediction, p < 0.05. Notably, cooperative suppressor effects were present in this model, as each 
predictor’s standardized coefficient was greater in absolute magnitude than the respective zero- 
order correlation. Regression coefficients and standard errors are displayed in Table 19.
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Table 19. Summary of multiple regression analysis at sixty day time-point. 
 
 
Model Summary 
 
 
Model 
 
 
R 
 
 
R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
 
1 .598
a
 .357 .304 125.24513 
a. Predictors: (Constant), Race, Age, BASRR 
b. Dependent Variable: Total Hours in 2 months 
 
 
ANOVA 
 
 
 
Model 
Sum of 
Squares 
 
 
df 
 
 
Mean Square 
 
 
F 
 
 
Sig. 
1          Regression 
 
Residual 
 
Total 
313937.034 3 104645.678 6.671 .001
a
 
564708.335 36 15686.343   
878645.369 39    
a. Predictors: (Constant), Race, Age, BASRR 
b. Dependent Variable: Total Hours in 2 months 
 
 
 
Unstandardized 
Coefficients 
 
 
Standardized 
Coefficients 
Coefficients 
95.0% Confidence 
Interval for B              Correlations
 
 
Model 
 
B 
Std. 
Error 
 
Beta 
 
t 
 
Sig. 
Lower 
Bound 
Upper 
Bound 
Zero- 
order 
 
Partial 
 
Part 
1(Constant) 75.187 123.235  .610 .546 -174.746 325.119    
Age 4.472 1.683 .357 2.657 .012 1.058 7.885 .327 .405 .355 
BASRR -14.057 4.338 -.449 -3.240 .003 -22.855 -5.259 -.322 -.475 -.433 
Race 109.024 41.917 .358 2.601 .013 24.012 194.036 .268 .398 .348 
a. Dependent Variable: Total Hours in 2 months
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Ninety days multiple regression model. A test of the full multiple regression model for 
total hours of CPAP use at the ninety day time-point included age and race as predictor variables. 
Two significant, positive correlations were observed between total hours of CPAP use at 90 days 
(M = 418.498, SD = 218..742) and predictor variables, including age (M = 55.711, SD = 11.747), 
r(47) = 0.304, p = 0.038, 95% CI [0.019, 0.543], and race (M = 1.680, SD = 0.498), r(46) = 
0.340, p = 0.021, 95% CI [0.056, 0.573], indicating that increased age and self-identifying as 
Caucasian were significantly associated with more total hours of CPAP use at 90 days. The 
assumptions of linearity, independence of errors, homoscedasticity, unusual points, and 
normality of residuals were met. These variables statistically significantly predicted total hours 
of CPAP use at the ninety day time-point, F(2, 43) = 6.499, p = 0.003, R
2 
= 0.232 95% CI 
[0.0327, 0.431]. Both variables added statistically significantly to the prediction, p < 0.05, 
although cooperative suppression was present in this model as each standardized coefficient was 
higher in absolute magnitude than the respective zero-order correlation. Regression coefficients 
and standard errors are displayed in Table 20.
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Table 20. Summary of multiple regression analysis at ninety day time-point. 
 
 
Model Summary 
 
 
Model 
 
 
R 
 
 
R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
 
1 .482
a
 .232 .196 197.94864 
a. Predictors: (Constant), Race, Age 
b. Dependent Variable: Total Hours in 3 months 
 
 
ANOVA 
 
 
 
Model 
Sum of 
Squares 
 
 
df 
 
 
Mean Square 
 
 
F 
 
 
Sig. 
1          Regression 
 
Residual 
 
Total 
509333.888 2 254666.944 6.499 .003
a
 
1684897.627 43 39183.666   
2194231.515 45    
a. Predictors: (Constant), Race, Age 
b. Dependent Variable: Total Hours in 3 months 
 
 
Coefficients 
 
 
 
 
 
Model 
Unstandardized 
Coefficients 
Stand. 
Coeffs 
 
 
 
 
t 
 
 
 
 
Sig. 
95% Confidence 
Interval for B 
 
Correlations 
 
 
B 
Std. 
Error 
 
Beta 
Lower 
Bound 
Upper 
Bound 
Zero- 
order 
 
Partial 
 
Part 
1 (Constant) 
Age 
Race 
-192.322 175.143  -1.098 .278 -545.532 160.887    
6.303 2.466 .342 2.556 .014 1.329 11.276 .317 .363 .342 
157.084 57.911 .363 2.713 .010 40.296 273.872 .340 .382 .362 
a. Dependent Variable: Total Hours in 3 months
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Correlations between BIS, BAS, and EEG asymmetry. Frontal asymmetry scores were 
calculated for overall alpha power by: 1) taking the natural log of the alpha power scores at each 
electrode, and 2) subtracting left alpha power scores from right alpha power scores at frontal 
electrodes (ln[alpha power at F4 electrode] – ln[alpha power at F3 electrode]). The inverse of 
this asymmetry score is believed to represent increased brain activity, thus negative scores reflect 
greater relative right hemisphere EEG activity, and positive scores reflect greater relative left 
activity (Davidson, 1988). 
Correlation analyses were performed to investigate the relationship between facets of 
Reinforcement Sensitivity Theory (e.g., BIS, BAS subscales, SPQ, and AMS) and overall EEG 
alpha asymmetry scores, which are presented in Table 21. No significant correlations were 
observed between alpha asymmetry scores and variables of interest.
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Table 21. Correlation matrix showing relationships between BIS, BAS Subscales, SPQ, AMS, 
  and overall alpha (8-12 Hz) asymmetry scores.          
 
 EC EO AMS SPQ BIS   BAS 
 
D            FS       RR 
BAS FS         
  
D 
          
.420** 
  
RR 
         
.008 
 
.205 
 
BIS 
         
.243* 
 
-.199 
 
-.181 
 
SPQ 
       
.409** 
  
-.006 
 
-.198 
 
-.203 
 
AMS 
      
.028 
 
-.244* 
  
-.105 
 
.374** 
 
.351** 
 
EO 
     
-.106 
 
-.102 
 
.101 
  
.109 
 
.047 
 
.137 
 
EC 
    
.663** 
 
-.120 
 
-.024 
 
.202 
  
-.039 
 
-.111 
 
.060 
 
Mean 
   
.10 
 
.066 
 
10.083 
 
8.89 
 
18.99 
  
16.21 
 
10.082 
 
10.11 
 
SD 
   
.29 
 
.25 
 
4.01 
 
5.90 
 
4.59 
  
4.33 
 
3.14 
 
2.98 
*p < .05; **p < .01 (two-tailed) 
Note. BIS = Behavioral Inhibition System Total, BAS = Behavioral Activation System, BAS RR 
= BAS Reward Responsiveness, BAS D = BAS Drive, BAS FS = BAS Fun Seeking, EC = alpha 
asymmetry score for eyes closed condition, EO = alpha asymmetry score for eyes open 
condition.
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Exploratory analyses. Primary logistic and multiple regression analyses along with 
primary correlation analyses led to several follow-up investigations regarding the nature of 
nonadherence behaviors at each time-point. 
Correlations at high, mid, and low alpha levels. First, primary correlation analyses 
investigating relationships between overall alpha asymmetry scores and facets of Reinforcement 
Sensitivity Theory did not replicate previous findings in the literature suggesting that relatively 
higher left hemispheric baseline frontal activity is associated with BAS traits while relatively 
higher right hemispheric baseline frontal activity is associated with BIS traits. Therefore, further 
correlation analyses were conducted after  alpha power was separated into high, mid, and low 
alpha levels in accordance with previous alpha asymmetry research (Crawford, Clarke, & Kitner- 
Triolo, 1996; Everhart, Demaree, & Wuensch, 2003). Correlation coefficients and descriptive 
statistics for these variables at high, mid, and low alpha levels are displayed in Tables 22-24. 
One significant correlation was observed between high alpha asymmetry scores (hEO; M 
 
= 0.078 microvolts, SD = 0.33) and BAS Fun Seeking scores (M = 10.11, SD = 2.98), r = 0.269, 
n = 54, p = 0.050, 95% CI [0.002, 0.500]. Another significant correlation was observed between 
low alpha asymmetry scores (lEC; M = 0.13 microvolts, SD = 0.35) and AMS scores (M = 
10.083, SD = 4.01), r = -0.277, n = 53, p = 0.045, 95% CI [-0.509, -0.008]. No other significant 
correlations were observed between high, mid, or low alpha asymmetry scores and BIS, BAS 
subscales, AMS, or SPQ.
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Table 22. Correlation matrix showing relationships between BIS, BAS Subscales, SPQ, AMS, 
  and high alpha asymmetry scores.                
 
 hEC hEO AMS SPQ  BIS  BAS 
 
D            FS       RR 
BAS FS        
  
D 
         
.420** 
  
RR 
        
.008 
 
.205 
 
BIS 
        
.243* 
 
-.199 
 
-.181 
 
SPQ 
       
.409** 
 
-.006 
 
-.198 
 
-.203 
 
AMS 
     
.028 
  
-.244* 
 
-.105 
 
.374** 
 
.351** 
 
hEO 
    
.029 
 
.129 
  
.253 
 
.154 
 
-.009 
 
.269* 
 
hEC 
   
.640** 
 
.078 
 
.008 
  
.221 
 
.061 
 
-.045 
 
.188 
 
Mean 
  
.078 
 
.078 
 
10.083 
 
8.89 
  
18.99 
 
16.21 
 
10.082 
 
10.11 
 
SD 
  
.35 
 
.33 
 
4.01 
 
5.90 
  
4.59 
 
4.33 
 
3.14 
 
2.98 
*p < .05; **p < .01 (two-tailed) 
Note. BIS = Behavioral Inhibition System Total, BAS = Behavioral Activation System, BAS RR 
= BAS Reward Responsiveness, BAS D = BAS Drive, BAS FS = BAS Fun Seeking, hEC = high 
alpha asymmetry score for eyes closed condition, hEO = high alpha asymmetry score for eyes 
open condition.
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Table 23. Correlation matrix showing relationships between BIS, BAS Subscales, SPQ, AMS, 
  and mid  alpha asymmetry scores.                 
mEC    mEO       AMS       SPQ        BIS                         BAS 
 
RR            D            FS 
 
BAS FS  
  
D 
        
.420** 
  
RR 
       
.008 
 
.205 
 
BIS 
       
.243* 
 
-.199 
 
-.181 
 
SPQ 
      
.409** 
 
-.006 
 
-.198 
 
-.203 
 
AMS 
     
.028 
 
-.244* 
 
-.105 
 
.374** 
 
.351** 
 
mEO 
    
-.058 
 
-.105 
 
.035 
 
.171 
 
.135 
 
.169 
 
mEC 
   
.479** 
 
-.120 
 
-.032 
 
.130 
 
-.129 
 
-.096 
 
-.020 
 
Mean 
  
.11 
 
.057 
 
10.083 
 
8.89 
 
18.99 
 
16.21 
 
10.082 
 
10.11 
 
SD 
  
.29 
 
.30 
 
4.01 
 
5.90 
 
4.59 
 
4.33 
 
3.14 
 
2.98 
*p < .05; **p < .01 (two-tailed) 
Note. BIS = Behavioral Inhibition System Total, BAS = Behavioral Activation System, BAS RR 
= BAS Reward Responsiveness, BAS D = BAS Drive, BAS FS = BAS Fun Seeking, mEC = mid 
alpha asymmetry score for eyes closed condition, mEO = mid alpha asymmetry score for eyes 
open condition.
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Table 24. Correlation matrix showing relationships between BIS, BAS Subscales, SPQ, AMS, 
  and low alpha asymmetry scores.                 
 
 lEC  lEO  AMS  SPQ  BIS  BAS 
 
D            FS          RR 
BAS FS            
  
D 
             
.420** 
  
RR 
            
.008 
 
.205 
 
BIS 
            
.243* 
 
-.199 
 
-.181 
 
SPQ 
           
.409** 
 
-.006 
 
-.198 
 
-.203 
 
AMS 
         
.028 
  
-.244* 
 
-.105 
 
.374** 
 
.351** 
 
lEO 
       
-.176 
  
-.077 
  
.034 
 
-.079 
 
-.156 
 
-.213 
 
lEC 
     
.496** 
  
-.277* 
  
-.033 
  
.123 
 
.003 
 
-.122 
 
.035 
 
Mean 
   
.13 
  
.14 
  
10.083 
  
8.89 
  
18.99 
 
16.21 
 
10.082 
 
10.11 
 
SD 
   
.35 
  
.33 
  
4.01 
  
5.90 
  
4.59 
 
4.33 
 
3.14 
 
2.98 
*p < .05; **p < .01 (two-tailed) 
Note. BIS = Behavioral Inhibition System Total, BAS = Behavioral Activation System, BAS RR 
= BAS Reward Responsiveness, BAS D = BAS Drive, BAS FS = BAS Fun Seeking, lEC = low 
alpha asymmetry score for eyes closed condition, lEO = low alpha asymmetry score for eyes 
open condition.
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Follow-up call investigations. Second, a small subset of participants (n = 20) was 
contacted via telephone after receiving an OSA diagnosis and their treatment apparatus. Patients 
were chosen for follow-up contact at random until the sample size of the primary adherence 
study achieved satisfactory power for completion of logistic and multiple regression analyses. 
The follow-up call consisted of a brief qualitative check-in regarding the patient’s understanding 
of the new diagnosis, as well as several forced-choice style questions regarding the patient’s 
recollections of the diagnostic visit with the healthcare provider. Patients were asked whether or 
not they remembered their healthcare provider explaining the benefits of adherence and the 
consequences of nonadherence, the valence of their emotional reaction to that information, and 
an indication of their adherence behavioral intentions on a 0-100 scale. Please refer to Appendix 
H to review the entire follow-up call script. 
Exploratory analyses were conducted to investigate the following questions: 
 
1. Did behavioral intentions of this sample predict adherence behavior? 
 
2. Did patients have a bias towards remembering positive/negative valence according to self- 
reported traits (i.e., BIS, BAS, SPQ, AMS)? 
3. Did remembering the benefits and/or consequences predict adherence behaviors? 
 
Descriptive statistics of exploratory analyses sample. The current sample consisted of 12 
men and 8 women. Demographic characteristics of this sample comprised of individuals self- 
identifying as Caucasian (n = 15) and African American (n = 5). The mean age of participants 
was 59.1 years, with a range from 38 to 93 years of age. The average BMI of the current sample 
was 38.774, indicative of Class II Obesity. BMI range consisted of individuals from the 
overweight BMI classification at 26.38 to very severely obese (Class III) at 69.41. There were no 
significant differences in adherence behavior between men and women at any time-point: 7 days,
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t(13) = -1.022, p = .326; 30 days, t(18) = -.976, p = .342; 60 days, t(8) = .300, p = .771; 90 days, 
t(7) = -.244, p = .814. There were also no significant differences in adherence among Caucasians 
and African Americans at any time-point: 7 days, t(13) = -1.487, p = .161; 30 days, t(18) = -.552, 
p = .588; 60 days, t(8) = -1.825, p = .105; 90 days, t(7) = -1.998, p = .086. Descriptive statistics 
of the self-report inventories, baseline asymmetry values, and behavioral intentions from the 
subsample of patients who participated in follow-up call are provided in Table 25. Frequency 
counts of participant responses to each follow-up question are displayed in Table 26.
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Table 25. Descriptive statistics of exploratory analyses subsample for variables of interest from 
self-report inventories and baseline asymmetry values. 
Predictor Variable Mean SD 
Age 59.100 14.768 
BMI 38.774 11.551 
Subjective Severity Rating 2.000 1.085 
AHI 23.521 18.086 
BIS 19.737 4.712 
BAS Drive 10.350 3.573 
BAS Reward Responsiveness 16.850 4.522 
BAS Fun Seeking 11.150 2.601 
Appetitive Motivation Scale 9.947 4.625 
Sensitivity to Punishment Questionnaire 9.579 6.535 
Eyes Open Baseline Asymmetry 0.0457 0.240 
Eyes Closed Baseline Asymmetry 0.0135 0.254 
Behavioral Intentions 91.316 16.317 
 
 
 
 
 
Table 26. Frequencies of participant responses to follow-up questions. 
Question 1: Did your physician explain the benefits of 
following treatment recommendations regularly? 
Yes No 
13 7 
Question 2: Did your physician explain the consequences of 
not following treatment recommendations 
regularly? 
Yes No 
10 10 
Question 3: Which would you say your 
doctor spent the most time 
highlighting: 
consequences or benefits? 
Consequences Benefits Equal 
3 12 5 
Question 4: How did you feel after your 
physician gave you this 
information? (valence) 
Positive Neutral Negative 
6 4 10 
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Behavioral intentions and adherence behavior. In order to investigate the predictive 
utility of self-reported behavioral intentions on adherence behavior, linear regression analyses 
were conducted for each time-point. A .05 criterion of statistical significance was employed for 
all tests. The linear regression between behavioral intentions and total hours of apparatus use in 
seven days was not significant, F(1, 13) = .230, p = .639, r
2 
= 0.017, 95% CI [0.000, 0.324]. 
Similarly, the linear regression between behavioral intentions and total hours of apparatus use in 
thirty days was not significant, F(1, 17) = .064, p = .803, r
2 
= 0.004, 95% CI [0.000, 0.207]. 
Linear regressions between behavioral intentions and total hours of apparatus use in both sixty 
and ninety day time-points were also not significant: sixty days, F(1, 8) = .001, p = .978, r
2 
= 
0.0001, 95% CI [0.000, 0.000]; ninety days, F(1, 7) = .046, p = .836, r
2 
=0.007, 95% CI [0.000, 
 
0.359]. While these findings do not support previous research findings indicating that behavioral 
intentions predict adherence behaviors (Blanchard, Courneya, Rodgers, Daub, & Knapic, 2002; 
Gatch & Kendziershi, 1990; Plotnikoff, Lippke, Trinh, Courneya, Birkett, & Sigal, 2010; 
Tulloch et al., 2009; White et al., 2010), it is important to note that the low sample size provides 
low power for these analyses. Thus, these results may represent a Type II error, as power was 
between 28-54% for a large effect (rho = .5). 
Self-reported traits associated with emotional bias. Spearman rank-order correlation 
analyses were conducted between self-reported trait characteristics, baseline asymmetry values, 
and overall emotional valence participants reported experiencing after receiving their OSA 
diagnosis and receiving treatment recommendations for using their apparatus. This was 
completed in order to explore the possible associations between predisposing traits and 
tendencies to remember positive or negative emotions, as consistent with Reinforcement 
Sensitivity Theory. In summary, no significant correlations were found between reported
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emotional valence after diagnostic appointment and any self-reported trait characteristics or 
baseline asymmetry values in this follow-up sample. 
As processing the consequences of nonadherence and benefits of adherence during a 
diagnostic appointment could potentially evoke emotions, correlation analyses were also 
conducted between self-reported traits and reported consequences and benefits during follow-up 
call. One significant correlation was observed between reported consequences (Yes = 1, No = 2) 
and BAS Reward Responsiveness, rs(18) = 0.523, p = 0.018, 95% CI [0.105, 0.784], indicating 
that people who reported higher levels of this trait were less likely to report remembering their 
healthcare provider explaining the consequences of nonadherence to their OSA apparatus. No 
other significant correlations were observed. 
Adherence behaviors associated with remembered benefits or consequences. Spearman 
rank-order correlation analyses were conducted between reported consequences and benefits 
during follow-up call and adherence behaviors at each time-point. One significant correlation 
was observed between reported consequences (Yes = 1, No = 2) during follow-up call and total 
hours of apparatus use in three months, rs(7) = -0.693, p = 0.039, 95% CI [-0.929, -0.054], 
indicating that remembering the consequences of nonadherence explained by their healthcare 
provider during the diagnostic appointment was associated with higher total hours of use in three 
months. No other significant correlations were observed at any other time-point. 
Summary of Findings 
 
In summary, partial support was observed for several of the main hypotheses for Study 
Two. It was hypothesized that BIS would be a predictor of nonadherence behavior, however, BIS 
was not found to be a significant predictor in any of the logistic or multiple regression models at 
any time-point. This is in contrast to prior research which established BIS as a predictor variable
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of nonadherence in a similar clinical sample (Moran et al., 2010), and does not support the 
present hypothesis. Although not specifically hypothesized, another facet of RST, BAS Reward 
Responsiveness, was found to be a significant, negative predictor of total hours of CPAP use at 
the 60 day time-point, indicating that patients who reported lower levels of this trait engaged in 
more hours of apparatus use by the 60 day time-point. As this subscale assesses anticipation of 
reward and is thought to be associated with approach-related behaviors consistent with the BAS 
construct, this finding appears to be incongruent with RST. However, BAS Reward 
Responsiveness as a construct has been criticized for being positively correlated with BIS and 
independent from the other BAS subscales in previous research (Cogswell, Alloy, van Dulmen, 
& Fresco, 2006; Gomez, Cooper, & Gomez, 2005). No other RST factors were significant 
predictors in any of the logistic or multiple regression models. 
It was also hypothesized that higher BAS scores would be associated with greater relative 
left frontal asymmetry while higher BIS scores would be associated with greater relative right 
frontal asymmetry from polysomnogram recordings. No significant correlations were observed 
between overall alpha asymmetry scores and variables of interest, which does not support the 
current hypothesis. Two significant correlations were observed when alpha power was stratified 
into high, mid, and low levels. One positive correlation was observed between high alpha values 
and BAS Fun Seeking, indicating patients who self-reported higher levels of this trait also had 
relatively greater left hemisphere baseline activity during polysomnogram study, which is in 
support of the current hypothesis. A negative correlation was observed between low alpha 
asymmetry and AMS scores, indicating patients who self-reported higher levels of this trait also 
had relatively greater right hemisphere baseline activity during polysomnogram, which does not 
support the current hypothesis as AMS is thought to approximate BAS.
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Finally, it was predicted that greater relative left frontal asymmetry would be associated 
with greater adherence behavior while greater relative right frontal asymmetry would be 
associated with lower adherence behavior. None of the baseline asymmetry variables were found 
to be significant predictors of any of the logistic or multiple regression models. Furthermore, 
exploratory analyses did not indicate any of the stratified alpha power variables to significantly 
predict total hours of use at any time-point using separate linear regression analyses. In 
summary, no support was found for the current hypothesis in the clinical sample. 
 
Several additional notable findings were observed from Study Two. Nonadherence was 
not predicted by any variables of interest in either logistic or multiple regression models at the 
seven day time-point. The logistic regression model at 30 days explained 7.8% of the variance of 
a model with age as a predictor variable. The logistic regression model at the 60 day time-point 
explained 28.9% of the variance in observed nonadherence and included one significant 
predictor, age, which indicated that for each one year reduction in age of this sample, the risk of 
nonadherence increased by a factor of 1.094. The multiple regression model at the 60 day time- 
point also included age as a significant predictor of total hours of CPAP use, but additionally 
included race (higher use associated with higher likelihood of identifying as Caucasian) and BAS 
Reward Responsiveness (higher use associated with lower endorsements of this trait) as predictor 
variables. 
The logistic regression model at the 90 day time-point explained 33.1% of the variance in 
nonadherence and included age and subjective severity rating as significant predictor variables. 
Interestingly, a one-unit increase in subjective severity rating of obstructive sleep apnea at the 
time of diagnosis is associated with the odds of demonstrating nonadherence by a multiplicative 
factor of 3.272. However, subjective severity rating was not a significant predictor of total hours
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of CPAP use at the 90 day time-point as it was demonstrated through multiple regression 
analysis. Age and race were the only predictor variables shown to significantly add to the 
prediction.
 CHAPTER VII: GENERAL DISCUSSION 
 
OSA is a common chronic sleep disorder with a demanding and complex treatment 
regimen. Fortunately, CPAP treatment is highly effective; unfortunately, many patients are 
unable to overcome complex barriers to adherence. The field is now recognizing the extent of 
these complexities and thus has called for a biopsychosocial approach to CPAP adherence. This 
dissertation aimed to investigate individual differences in predisposing traits and 
electrophysiology in accord with this biopsychosocial framework. In summary, two studies were 
conducted in an effort to delineate predictors of behavioral intentions and adherence behaviors, 
as well as investigate a practical message framing approach that is informed by individual 
differences. 
A specific aim of this study was to investigate predictive variables of behavioral 
intentions and CPAP adherence. This was addressed in both studies through multiple regression 
analyses as well as through logistic regression analyses in the clinical study in accordance with 
current CPAP adherence criteria. Two multiple regression models were tested in Study One. A 
full multiple regression model predicting behavioral intentions to adhere to the advantage-framed 
health message was significant, including BIS, Active Planning, Humor, Valence and Control 
SAM ratings to the advantage-framed message, and eyes open baseline asymmetry values. The 
full model explained 28.1% of the variance in behavioral intentions, and revealed two significant 
predictors: Valence ratings and BC: Humor, such that more positive valence ratings on the SAM 
and lower Humor ratings on the Brief COPE were associated with higher behavioral intentions. 
A full multiple regression model predicting behavioral intentions to adhere to the disadvantage- 
framed health message was also significant, including BIS, BC: Humor, AdvSAMC, DisSAMC, 
and baseline asymmetry values at two eyes open conditions and one eyes closed condition. The
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full model predicted 30.8% of the variance, and revealed SAM Control ratings to the advantage- 
framed message, baseline asymmetry during the eyes closed condition, and BC: Humor as 
significant predictors. Specifically, participants with higher scores on AdvSAMC and lower 
scores on BC: Humor were expected to indicate higher behavioral intentions to adhere to the 
disadvantage-framed message. EC3 also had a significant negative regression weight, indicating 
that participants with higher relative right hemisphere baseline cortical activity were expected to 
endorse higher behavioral intentions to adhere to the disadvantage-framed message. 
Study Two indicated that both logistic and multiple regression models were significant at 
the 60 and 90 day time-points. Age and subjective severity rating explained 28.9% of the 
variance in nonadherence at the 60 day time-point and correctly classified 66.7% of cases, 
although age was the only significant predictor variable, most likely reflecting the general 
increased risk of nonadherence with younger age as described in the literature. The same 
variables were found to explain 33.1% of the variance in nonadherence at the 90 day time-point, 
and correctly classified 65.1% of cases. Both variables were significant predictors at the 90 day 
time-point, with a one-unit increase in self-reported subjective severity rating associated with the 
odds of being nonadherent by a multiplicative factor of 3.272. Multiple regression models at 
these time-points similarly include age as a significant predictor, but with the addition of race in 
both models and BAS Reward Responsiveness as a negative predictor of total hours of CPAP 
use at the 60 day time-point model. A summary of findings is displayed in Table 27.
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Table 27. Significant predictors of each significant regression model. 
 
Lab Study: Behavioral Intentions   
 
Dependent Variable:              Behavioral intentions to adhere to advantage-framed message. 
Significant Predictors:            (+) SAM Valence ratings to advantage-framed message, 
and (-) BC: Humor 
 
Dependent Variable:              Behavioral intentions to adhere to disadvantage-framed message. 
Significant Predictors:            (+) BIS, (+) SAM Control ratings to advantage-framed message, 
(-) baseline asymmetry during the eyes closed condition, 
and (-) BC: Humor 
 
Follow-Up Calls   
 
Dependent Variable:              Behavioral intentions to adhere to CPAP treatment. 
Significant Predictors:            No significant predictors (low sample size, low power) 
 
CPAP Nonadherence: Logistic Regression Models   
 
Dependent Variable:              Nonadherence at the 60 day time-point. 
Significant Predictors:            Age 
 
Dependent Variable:              Nonadherence at the 90 day time-point. 
Significant Predictors:            Age and Subjective Severity Rating 
 
Total Hours CPAP Use: Multiple Regression Models   
 
Dependent Variable:              Total hours of CPAP use at 60 day time-point. 
Significant Predictors:            (-) BAS Reward Responsiveness, (+) Age, and (+) Race 
 
Dependent Variable:              Total hours of CPAP use at 90 day time-point. 
Significant Predictors:            (+) Age, and (+) Race 
 
 
 
 
Another aim of this study was to investigate a practical message framing approach that is 
informed by individual differences from formal hypothesis testing and exploratory analyses. 
Importantly, no significant differences were found between behavioral intentions ratings after 
viewing either of the health messages without taking into account individual differences in traits, 
coping strategies, and resting frontal cortical asymmetry, emphasizing the importance of
119  
considering patient characteristics at the individual level instead of assuming one general 
approach will work across all patients. Some practical information that can perhaps be garnered 
from findings across health message conditions is the importance of considering elicitation of 
affect throughout provision of diagnosis and treatment recommendations. For example, clinicians 
may help patients to better connect with advantage-framed health messages by ensuring that they 
are concurrently experiencing positively valenced emotions in immediate response to receiving 
the information. If clinicians are delivering disadvantage-framed health messages, it may be 
beneficial for clinicians to enhance the patient’s feelings of control by engaging in motivational 
interviewing techniques and also being willing to process feelings of anxiety or fear associated 
with receiving such a health message. 
Regarding the association between relatively greater right hemisphere activity and 
behavioral intentions to adhere to the disadvantage-framed message, right hemisphere activity 
has been previously associated with traits that are sensitive to punishment stimuli, meaning they 
are more likely to orient to negative cues in their environment. Perhaps this finding is a 
biomarker of this tendency to seek out threatening cues or to attend more highly to 
consequences. This could indicate that when delivering health information in a clinical setting, 
providers could deliver disadvantage-framed information in a way that meaningfully and safely 
highlights what is most important to people based on their trait characteristics. In the case of 
someone who may perhaps have this biomarker, and thus may appear more behaviorally anxious, 
highlighting the disadvantages of nonadherence while concurrently activating the patient’s 
feelings of control could provide an optimal environment for increased behavioral intentions to 
adhere to CPAP treatment.
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Although the follow-up call exploratory analyses were limited by low power due to low 
sample size, two significant findings were revealed. A significant correlation was observed 
between remembering the healthcare provider explaining the consequences of nonadherence and 
BAS Reward Responsiveness, indicating that people who reported higher levels of this trait were 
less likely to report remembering their healthcare provider explaining the consequences of CPAP 
nonadherence. Another significant correlation was observed between remembering the 
healthcare provider explaining the consequences of nonadherence and total hours of apparatus 
use at the 90 day time-point. This indicates that self-reported remembering the consequences of 
nonadherence explained by their healthcare provider during the diagnostic appointment was 
associated with higher total hours of use in three months. While BAS Reward Responsiveness 
was not significantly correlated with total hours of apparatus use at the 90 day time-point, the 
potential exists that people who are higher on this trait could be at higher risk of not orienting to 
the consequences of nonadherence explained during a diagnostic visit, and may need to have 
such health messages framed to enhance their likelihood of adherence in another way. 
Regarding coping strategies, it is interesting to note that humor was a negatively 
weighted significant predictor of behavioral intentions to adhere to both health messages. Out of 
the three previously described health behavior models, coping is most directly measured in the 
PMT in the coping appraisal construct of the cognitive decision-making process. Perhaps humor 
as a general coping strategy that may be mostly adaptive in other contexts may actually be 
working against an individual’s ability to emotionally process the negative consequences 
associated with CPAP nonadherence, thus leading to less behavioral intentions to protect oneself 
from those consequences. This is consistent with PMT in that fear arousal is a mechanism 
driving an individual’s motivation to avoid the negative consequences of not adopting a health
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behavior. It could be that humor as a coping strategy acts as a moderator of this fear arousal 
mechanism, thus leading to decreased behavioral intentions. 
Findings from Study Two indicated that patients identifying as African American were at 
higher risk of nonadherence to CPAP, especially after 60 days. This is consistent with recent 
findings highlighting adherence disparities particularly among black CPAP patients when 
compared to white and Hispanic/Latino patients (Billings et al., 2011). Findings in the literature 
also suggest that follow-up with health care providers for CPAP-treated OSA may also be lower 
among minority groups (Greenberg et al., 2004), which increases the chances that patients will 
suffer continued OSA symptoms and exacerbation of symptoms of other common co-occurring 
health problems, such as cardiovascular and metabolic diseases (Javaheri, 2011). 
It is also worth noting that during the current study, multiple regression analyses using 
total hours of CPAP use as the dependent variable were more sensitive at identifying those at risk 
of nonadherence (i.e., African Americans in this sample) than logistic regression analyses using 
the more restrictive current adherence criteria (i.e., over four hours of use 70% of nights). This is 
consistent with a recent call for future research that includes investigations of factors that could 
provide more meaningful translation to clinical practice, especially in light of findings 
suggesting such disparities exist among minority groups, those living in urban environments or 
neighborhoods of low socioeconomic levels, and those with lower education and literacy levels 
(Sawyer, 2013). 
Younger patients in the current clinical sample were also at increased risk of 
nonadherence, consistent with previous research. Findings also indicated that patients were at 
higher risk of nonadherence after 90 days if they reported higher subjective severity of their 
sleep problem prior to diagnosis. This finding could possibly indicate that these patients had
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given up on attaining symptom relief from using CPAP given their high severity of symptoms at 
diagnosis. It could also indicate that they had discontinued CPAP use due to achieving relative 
symptom relief. Risk of nonadherence was also associated with higher BAS Reward 
Responsiveness trait and not remembering the consequences of nonadherence from their 
healthcare provider at diagnosis. Humor as a coping strategy was associated with decreased 
behavioral intentions to adhere to both health messages in the laboratory study. 
Strengths from the laboratory study included the ability to control for variables otherwise 
impossible to control in a clinical sample, while strengths from the clinical study allowed for 
possible generalizability to other patients suffering from OSA. A limitation of the laboratory 
study was that although much practical information has been gained from testing two differently 
framed health messages, it should be emphasized that this was not an intervention study as there 
was no control group for comparison of the effect of the health messages. A major assumption 
made during Study One was that behavioral intentions reliably predicted adherence behavior, as 
demonstrated in the health behavior literature. The follow-up call investigation was designed to 
test the predictive utility of behavioral intentions on CPAP adherence in the clinical sample, but 
unfortunately the small sample size provided low power to test this assumption, and thus reflects 
a significant limitation of the present study. Furthermore, although the follow-up call 
investigation was focused on patients’ subjective recall of the content of their diagnostic 
appointments, it should be noted that it was impossible to determine the extent to which each 
provider reviewed the consequences and benefits of CPAP adherence as no observers were 
present during these appointments. 
A significant limitation of the clinical study was that not all participants had adherence 
data available at all time-points. At present, there is no unified way to determine adherence, as
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the home health care companies each have their own method and format for CPAP use data 
collection. Furthermore, they do not always release these data to providers, even though CPAP 
use data are crucial for determining whether or not patients are able to keep the CPAP machine 
for treatment. Notably, suppressor effects were identified in the 60 and 90 day time-points 
models and represent limitations in interpretation of these data. Additionally, the method of 
eliminating variables for inclusion into regression models based on Pearson correlations to 
account for power limitations given the number of variables currently under investigation in the 
behavioral sleep medicine literature may have also resulted in additional limitations at 
identifying significant predictors of nonadherence. An additional limitation is that those patients 
who chose to participate in the clinical study may be qualitatively different in some way than 
those who chose not to participate, which may threaten generalizability to the OSA population. 
Future research should continue similar investigations of individual differences in 
predisposing traits and neurophysiology that attempt translation of laboratory experimental study 
into clinical investigations of tested constructs. It will be especially important to focus future 
research on those identified as at higher risk of CPAP nonadherence in order to enhance 
likelihood of adherence given the many health benefits of OSA treatment. Findings from the 
current study indicated that African Americans were at higher risk of CPAP nonadherence 
through multiple regression analyses, but not through logistic regression analyses using more 
restrictive current adherence criteria. This is important because additional health benefits and 
OSA symptom relief are associated with increased CPAP use beyond the current adherence 
criteria, thus using total hours of CPAP use instead of a dichotomous adherence outcome 
variable may help to identify possible disparities in care. Additionally, continuing similar 
investigations of individual differences in predisposing traits, neurophysiology, and coping
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strategies will allow providers to tailor their approach with patients to enhance likelihood of 
adherence. 
Future research could focus on testing the assumption that behavioral intentions predict 
adherence behaviors by completing a similar follow-up call investigation with a greater sample 
size to increase power. Given the practical information gained from Study One regarding health 
message framing, it would be beneficial to test the effects of these messages by including a 
control group in a follow-up laboratory study.  Ideally, these findings could then be used to 
deliver education to providers on message framing to enhance CPAP adherence, which could 
then be subsequently tested in a clinical setting. 
It is important to continue uncovering additional mechanisms driving CPAP 
nonadherence through a biopsychosocial framework. As patients face many barriers to 
adherence, it is tempting as health professionals to try to help patients by assuming we conceive 
of these barriers in the same manner as our patients, when in actuality it is the patients’ unique 
perspectives that are crucial for enhancing their experience with a complex treatment such as 
CPAP. 
Boyer’s (2007) statement especially rings true in this manner: 
 
Health professionals of all disciplines need to resist the temptation to conceive of 
noncompliance or nonadherence as a condition that “a patient has.” More instrumentally 
useful is the investigation of the factors that facilitate a patient’s success with self- 
management or follow-through with the medical regimen, and factors that increase a 
patient’s difficulties or failures with self-management or follow-through with the medical 
regimen. By identifying the factors that contribute to either success or difficulties with 
self-management, the medical team can identify the means to help a patient, or the 
patient’s family, succeed with the demands of that particular treatment regimen. (p. 15) 
 
This is consistent with the formal call from Crawford and colleagues (2014) for a 
biopsychosocial approach to addressing CPAP adherence. This approach emphasizes movement 
away from a “doctor-centered” model of compliance where the main mechanism of change is the
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passive obedience of the patient to a doctor’s recommendations, and towards a more holistic 
model emphasizing the multidimensional nature of adherence. The current study was designed to 
investigate nonadherence from a biopsychosocial standpoint by considering the barriers of 
success from the patient’s subjective experiences of receiving a health diagnosis and subsequent 
treatment recommendations given their predisposing traits. By considering these complex 
patient-centered factors, significant predictors were revealed, such as subjective severity ratings 
of the sleep problem prior to diagnosis, and subjective reports of remembering nonadherence 
consequences explained during diagnostic appointment. 
Studying patient-centered factors through the laboratory study uncovered matters with 
potentially significant clinical applicability. For example, this investigation revealed that humor 
as a coping strategy was a significant negative predictor of behavioral intentions to adhere to 
both advantage- and disadvantage-framed health messages, suggesting that people with this 
coping strategy may require different approaches to enhance adherence likelihood. Furthermore, 
the findings associated with participants’ emotional responses to advantage- and disadvantage- 
framed health messages can also provide clinical utility to enhance the transactions between 
patients and providers. This focus on the transactions between patients and providers is in line 
with the call for a biopsychosocial approach. This focus emphasizes the importance of 
collaborating with patients in consideration of not only condition- and therapy-related factors 
wherein providers can offer their expertise, but also in consideration of patient-related factors 
wherein patients can offer their expertise in their subjective experiences within the healthcare 
system as well as the unique coping strategies they bring with them into a likely stressful point of 
intervention. Continued research with this biopsychosocial focus will allow providers to consider
126  
practical approaches to delivering novel health information that can enhance the likelihood of 
adherence based on patient-centered factors.
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 APPENDIX D 
 
Summer Recruitment Script 
 
Greetings, 
 
My name is Katie Lehockey and I am a clinical health psychology doctoral student 
conducting research to complete my dissertation.  I’m here today to see if anyone is interested in 
participating in my experiment. 
 
The purpose of my research is to find out how people with different personalities 
perceive incoming health information, like receiving a health diagnosis. By doing this research, I 
hope to learn more about how personality is related to intentions to adhere to treatment and mood 
states. 
 
If you are interested in participating, you will be asked to come to the Cognitive 
Neuroscience Lab in the Rawl building for two hours.  During the first half hour, you will 
complete some surveys about your personality and feelings.  The rest of the time you will be 
completing the experiment.  It is important to note that this study will use electroencephalogram 
(EEG).  EEG is a recording of your brain’s electrical activity, which is very useful for studying 
inhibition. 
 
If you are 18 years of age or older, right-handed, have corrected-to-normal vision, do not 
have any neurological or psychiatric conditions like a seizure disorder, anxiety, or depression, 
and have never received a diagnosis of obstructive sleep apnea, then you are eligible to 
participate in this study.  Please indicate your interest in participating by printing your name and 
contact information on the paper provided.  I will contact you with more information about the 
study as soon as possible.  You may also contact me with any questions or concerns you may 
have about the experiment or your eligibility to participate.  Thank you for your time and 
consideration.
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Demographic Information Interview Form 
 
General Information 
Age:    Years of Education (from 1
st  
Grade):    Sex: Male       Female  
Are you left or right-handed? Left   Right  
Have you ever been diagnosed with obstructive sleep apnea?  Yes   No  
 
Medical History Questionnaire 
 
Have you ever experienced or been diagnosed with any of the following, or are you experiencing 
any of the following at present?  Please circle the appropriate response and explain any “Yes” 
answers below. 
 
1.  Visual difficulties, blurred vision, or eye disorders                                  Yes                 No 
 
2.  Blindness in either eye                                                                              Yes                 No 
 
3.  If Yes to either of the above, have problems been corrected                    Yes                 No 
 
4. Hearing problems                                                                                       Yes                 No 
 
5. Learning disabilities (problems of reading, writing, or                             Yes                 No 
comprehension) 
 
6. Cognitive problems                                                                                    Yes                 No 
 
7. Severe head trauma/injury                                                                         Yes                 No 
 
8.  Stroke                                                                                                        Yes                 No 
 
9. Epilepsy or seizures                                                                                   Yes                 No 
 
10. Neurological surgery                                                                                Yes                 No 
 
11. Paralysis                                                                                                   Yes                 No 
 
12.  Anxiety disorders                                                                                    Yes                 No 
 
13. Depression                                                                                                Yes                 No 
 
14. Other Neurological, Psychological, or Emotional problems                   Yes                 No
 APPENDIX F 
 
Instructions for Health Messages Task 
 
Pretend that you have completed an overnight sleep study because your close friend, 
roommate, relative, or significant other noticed that you snore very loudly at night. You have 
also noticed that you are feeling sleepy during class and are experiencing headaches every week. 
You have now returned to speak with your physician about the results and treatment 
recommendations. Please pay close attention to each message and the researcher will guide you 
through your remaining tasks.
158  
Advantage-Framed OSA Message Script 
 
Hi, my name is Dr. Jones and we are going to go over your sleep study results. It appears 
that you do in fact have obstructive sleep apnea. Obstructive sleep apnea is a condition where the 
flow of air pauses or decreases when you are sleeping. This generally happens because the 
airway has become narrowed, blocked, or floppy. The snoring you have been experiencing is 
caused by the air trying to squeeze through the narrowed airway. 
Since your airway becomes blocked when you sleep, the goal of treatment is to keep the 
airway open so that your breathing does not stop. The device that you will be given does just 
that. The CPAP machine will deliver slightly pressurized air at night when you wear it, keeping 
your airway open. It is recommended that you wear your CPAP every night while you sleep. 
People who regularly wear their CPAP report experiencing feeling more alert and less 
sleepy during the day. They also say that their concentration and memory is better, and they are 
more productive during the day. People typically report less anxiety and are in a better mood 
overall. An added bonus is that their partner or roommate’s sleep also improves. People who 
regularly wear their CPAP are decreasing risk of hypertension, Type II diabetes, and stroke.
159  
Disadvantage-Framed OSA Message Script 
 
Hi, my name is Dr. Jones and we are going to go over your sleep study results. It appears 
that you do in fact have obstructive sleep apnea. Obstructive sleep apnea is a condition where the 
flow of air pauses or decreases when you are sleeping. This generally happens because the 
airway has become narrowed, blocked, or floppy. The snoring you have been experiencing is 
caused by the air trying to squeeze through the narrowed airway. 
Since your airway becomes blocked when you sleep, the goal of treatment is to keep the 
airway open so that your breathing does not stop. The device that you will be given does just 
that. The CPAP machine will deliver slightly pressurized air at night when you wear it, keeping 
your airway open. It is recommended that you wear your CPAP every night while you sleep. 
People who do not regularly wear their CPAP continue to experience excessive 
sleepiness and fatigue during the day, and often continue to perform worse at school and work. 
They also say that their concentration and memory gets worse. People also say that they become 
more anxious and depressed as time goes on. In addition, their partner or roommate’s sleep also 
suffers if they do not regularly wear their CPAP because they continue to snore. People who do 
not regularly wear their CPAP are putting themselves at higher risk of hypertension, Type II 
diabetes, and stroke.
 APPENDIX G 
General Instructions 
You are now ready to begin the experimental phases of this study. You are sitting in a sound- 
proof booth, so I will be talking to you through an intercom to your left. 
 
It is very important that you remain still and relaxed during these sessions. Please do not grind 
your teeth or clinch your jaw. Please do not move your face more than usual, and try not to touch 
your face. If you feel one of the electrodes falling off of your face or ears, I’ll be able to tell on 
the software and will come in after the task session is finished to fix it. Please do not try to fix it 
yourself. 
 
Please pay attention to the pictures on the screen and remain alert at all times. At the end of the 
experiment, you will complete a brief quiz about what you saw during the study. You should do 
very well on it if you pay close attention.
161  
Eyes Open, Eyes Closed (Baseline Recording) 
For the next 8 minutes, I will be asking you to open and close your eyes over the intercom. 
When I ask you to open your eyes, please keep your eyes open normally and keep your gaze 
forward toward the computer monitor. You may blink normally. 
 
When I ask you to close your eyes, simply close your eyes naturally without squinting or moving 
many of your facial muscles.
162  
Positive Target 
 
For the next several minutes, you will see many different pictures on the computer screen. Many 
of them will make you feel negative emotions, while some of them will make you feel positive 
emotions. 
 
Please count silently to yourself the number of positive pictures you see on the screen. Please 
pay attention to each picture, and be ready to report the number of positive pictures you see to 
me at the end of the task.
163  
Negative Target 
 
For the next several minutes, you will see many different pictures on the computer screen. Many 
of them will make you feel positive emotions, while some of them will make you feel negative 
emotions. 
 
Please count silently to yourself the number of negative pictures you see on the screen. Please 
pay attention to each picture, and be ready to report the number of negative pictures you see to 
me at the end of the task.
 APPENDIX H 
 
Post-Diagnosis Session Follow-Up Script 
Hi, my name is and I’m calling from the Vidant Sleep Center Research Team.
This is the follow-up call from the study you participated in before your polysomnogram.  Do 
you have about 5 minutes to answer a few questions? 
 
My records indicate that you had a recent appointment for sleep apnea with Dr.                 . 
Please tell me a little bit about what happened during the appointment. (Confirm sleep apnea 
diagnosis) 
 
 
 
 
 
 
 
Thank you for this information! I have a few more questions for you. 
Did your physician explain the benefits of following treatment recommendations regularly? 
If so, please list them. 
 
 
 
 
 
 
Did your physician explain the consequences of not following treatment recommendations 
regularly? 
 
If so, please list them. 
 
 
 
 
 
 
Which would you say your doctor spent the most time highlighting: consequences or benefits? 
 
How did you feel after your physician gave you this information? 
 
 
 
 
 
Please tell me on a scale from 0-100% how likely you are to adhere to treatment: 
 
0------- 10------20------30------40------50------60------70------80------90------100 
 
Not at all likely                                                                                  Absolutely certain
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